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ABSTRACT 
The purpose of this research has been to investigate the mechanisms of chiral 
separations by high performance liquid chromatography (HPLC). While both cyclodextrin-
based chiral stationary phases (CSPs) and macrocyclic glycopeptide-based CSPs were 
utilized, the goal was to develop a method of interrogating chiral separations that is 
applicable to all CSPs. This dissertation focuses on the development and application of this 
approach. The macrocyclic glycopeptide CSPs were used to experimentally test this 
model/approach and to provide proof of principle. 
The linear solvation energy relationship (LSER), developed by Kamlet, Taft, and 
Abraham, was selected for its ability to de-convolute the interactions a solute experiences in 
a biphasic system. The theory states that the logarithm of a partition coefficient of a solute is 
equal to the sum of the interactions the solute experiences in the two phases. The LSER 
model has a term for each type of solvation interaction. These include interactions through 
polarizable n- and ^-electrons (eE), dipolar interactions (sS), hydrogen bond acceptance (aA) 
and donation (bB), and dispersion forces (vV). There are two components for each of the 
terms of the LSER equation, one term describing the systems ability to interact in the 
specified manner, and one term describing the solute's ability to interact in the specified 
manner. The lower case variables describe the characteristics of the system, and are called 
system constants. The uppercase variables describe the characteristics of the solute, and are 
called solute descriptors. The system constant c contains the phase ratio. 
My initial investigations of the macrocyclic glycopeptide CSPs produced unusual 
results involving the interactions attributed to polarizable n and n electrons. These results 
prompted me to first investigate the variety of interactions encoded in the polarizable 
Vil 
electron term (e-term) of the LSER equation. My initial interpretation of the interactions 
encoded by this term was that it described % electron association. I determined the system 
constants for several chromatographic stationary phases that contained varying aromatic and 
ionic character, and concluded that both % electron complexation and ion-dipole interactions 
are encoded by the e-term of the LSER model. 
Next, I examined the system constants obtained from liquid chromatography utilizing 
macrocyclic glycopeptide CSPs in the reversed-phase mode and the normal-phase mode. 
The system constants obtained from macrocyclic glycopeptide CSPs are compared with each 
other and conventional stationary phases. In the reversed-phase mode, the magnitude of the 
system constants are very different compared with conventional octadecyl stationary phases 
and the sign of the dipolar s-terms for all four macrocyclic glycopeptide CSPs is opposite 
that of conventional octadecyl silane-bonded stationary phases. In the normal-phase mode, 
the signs of the system constants for the four macrocyclic glycopeptide CSPs are the same as 
for conventional normal-phase stationary phases, although the value of the e-term 
(interaction through polarizable n and n electrons) is indistinguishable from zero. 
With knowledge of the system constants for the CSPs, it is possible to determine the 
solute descriptors of each enantiomer. Using multiple linear regression analysis, with the 
system constants of a chiral stationary phase (at multiple mobile phase 
compositions/temperatures) as the independent variables and the logarithm of the retention 
factor of one enantiomer as the dependent variable, the solute descriptors for each enantiomer 
are determined. The differences in the solute descriptors reveal the relative importance of 
each intermolecular interaction in generating enantioselectivity. 
I first attempted this method of analysis in the reversed-phase mode with the 
teicoplanin CSP. Several neutral compounds and amino acids were eluted with 
ethanol/buffer (0.020M triethylamine acetate, pH=4.1) mobile phases, and the solute 
descriptors for each enantiomer were determined by using the above described method. The 
statistical fits of the regression were excellent (the coefficient of correlation, r2, is typically 
greater than 0.98). It was found that steric repulsions and ion-dipole interactions had the 
strongest influence on enantioselectivity, with both types of hydrogen bonding having a weak 
influence on enantioselectivity. Dipolar interactions were found to be unimportant in 
generating enantioselectivity. 
I next attempted to apply the same method of analysis to data obtained from the 
normal-phase mode with a teicoplanin CSP. Ethanol/heptane solutions were utilized as 
mobile phases, and the ratio of ethanol to heptane and the column temperature were varied to 
generate an array of system constants. The regression fit for each set of system constants 
was quite good (the coefficient of correlation, r2, was often greater than 0.98), but there was a 
high degree of intercorrelation between the sets of system constants (the r2 was as high as 
0.97). Fluorinated solvents were utilized to decrease the degree of intercorrelation. Several 
neutral compounds were eluted with mobile phases composed of ethanol/heptane, 
ethanol/ethoxynonafluorobutane, and 2,2,2-trifluoroethanol/ethoxynonafluorobutane. The 
solute descriptors for the enantiomers of 5-methyl-5-phenyl-hydantoin were determined and 
then used to determine which intermolecular forces influence enantioselectivity in the 
normal-phase mode. It was found that dipole-dipole interaction and steric repulsion 
interactions were most important in generating enantioselectivity, and it electron 
complexation interactions were important, but less important than dipole-dipole interaction 
ix 
and steric repulsion interactions. Hydrogen bonding was found to be rather unimportant in 
generating enantioselectivity. 
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Chapter 1 
General Introduction and Literature Review 
1.1 General Introduction 
Enantiomeric separations and analyses continue to be an important field in science 
and technology. It has been well established that the enantiomers of a chiral compound can 
have different biological activities [1, 2], In pharmaceutical development, nutrition, and 
biotechnology, the determination of the activity of each enantiomer is a critical step and one 
required by regulatory agencies [3], As new chemical entities are developed, the methods to 
obtain individual enantiomers for this testing are also needed. 
The pathways to obtaining individual enantiomers fall into four categories: 
asymmetric synthesis and catalysis, biological catalysis, synthesis from the chiral pool, and 
resolution/separation methods. My focus has been to develop and improve separation 
methods and better understand the process of chiral recognition. By improving our 
understanding of the intricacies of the chiral recognition process, one can improve the 
methods used to obtain individual enantiomers. Additionally, the possibility exists to 
transpose these findings to other methods used to obtain individual enantiomers. 
In my study of enantiomeric separations and chiral recognition, I have chosen to 
study the macrocyclic glycopeptide chiral stationary phases (CSPs). They are one of the 
newest and the fastest growing class of chiral selector since their introduction in 1994 by 
Armstrong [4], They have proven to be very versatile, having excellent enantioselectivity for 
amino acids (derivatized and underivatized), di- and tri-peptides, sulfoxides, 
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dihydrofurocoumarins, hydroxy-acids, amino esters, imides, hydantoins, oxazolidinones, 
nonsteroidal antiinflammatories, ^-adrenergic blocking agents, as well as other 
pharmaceuticals and agrochemicals [5]. While there has been a great deal of interest in this 
class of chiral selector, the vast majority of work has focused on the application of the 
technology to achieve enantiomeric separations and there have been only a few studies 
pertaining to the mechanism of enantioseparation. 
The goal of this research is to improve our understanding of enantiomeric separations. 
The investigations performed utilized the macrocyclic glycopeptide CSPs in HPLC and this 
concept can be extended to other chiral selectors and other separation techniques. 
This dissertation begins with a general introduction and a literature review of the 
fields relevant to the presented research. It is followed by four complete scientific papers 
including all relevant supporting information. These papers focus on the development and 
application of the selected method to interrogate and better understand chiral recognition. 
The final chapter contains general conclusions. 
1.2 Literature Review - Macrocyclic Glycopeptides as Chiral Selectors for 
HPLC 
Macrocyclic glycopeptide based chiral stationary phases (CSPs) are among the most 
broadly applicable CSPs available today. Introduced as chiral selectors in 1994, four CSPs 
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have been developed into commercially viable products. They are multimodal stationary 
phases, effective in the normal-phase mode, the reversed-phase mode, and the polar organic 
mode. Additionally, they have been utilized in sub/supercritical fluid chromatography. They 
are useful on the analytical scale for the determination of enantiopurity, as well as on the 
preparative scale to obtain gram-scale or larger quantities of single enantiomers. The four 
commercially available macrocyclic glycopeptide CSPs are complementary to each other; 
often if one of the macrocyclic glycopeptide CSPs is able to partially separate a pair of 
enantiomers, a different macrocyclic glycopeptide CSP is able to produce a baseline 
separation. 
1.2.1 Structural features and properties of the most commonly utilized macrocyclic 
glycopeptides 
The four macrocyclic glycopeptides that are most commonly used as chiral selectors 
were originally discovered by scientists at Eli Lilly & Company in the 1950s [6]. The three 
compounds, vancomycin, ristocetin A, and teicoplanin, are produced during fermentation of 
Streptomyces orientalis, Nocardia lurida, and Actinoplanes teichomyceticus, respectively [6-
10]. Teicoplanin aglycon is produced by the removal of the sugar moieties via acid 
hydrolysis [11]. 
These four compounds have many structural features in common. Figure 1 gives the 
structures of vancomycin, ristocetin A, teicoplanin, and teicoplanin aglycon. All four 
compounds have a peptide chain, beginning with the amine group on the right hand edge of 
each structure, and terminating at the carboxylic acid residue on the left hand edge of each 
structure. Both the amine and the carboxylic acid groups are ionizable and are usually 
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ionized in the presence of aqueous and hydro-organic solvent mixtures [7], In the case of 
ristocetin A, the carboxylic acid group is esterified (as a methyl ester). Most of the side 
chains of the peptide are phenolic residues, and many of these phenolic groups are linked to 
one another. These cross-linked phenolic residues on the main chain create macrocyclic 
rings that give these molecules a basket-like shape. Ristocetin A, teicoplanin, and 
teicoplanin aglycon have four fused macrocyclic rings, while vancomycin has three fused 
macrocyclic rings. 
Molecular modeling was utilized to study the shape of first three macrocyclic 
glycopeptides (vancomycin, ristocetin A, and teicoplanin) [12]. Energy minimized structures 
were generated and compared with each other. The three compounds all appeared to have 
similar "C-shaped" aglycon baskets, but the degree of openness of the basket and the helical 
twist varied between the three compounds (Figure 2A). Vancomycin was found to have the 
most open aglycon basket, with an edge-to-edge distance of 9.3 Â, and teicoplanin was found 
to have the most closed aglycon, having an edge-to-edge distance of 4.5-5.5 À. Ristocetin A 
had intermediate edge-to-edge distances of 5.2-8.8 Â. The variations in the edge-to-edge 
distances of the aglycon baskets were attributed to the helical twist of the aglycon, which 
makes some edges of the aglycon closer to each other compared with other edge pairs. 
Helical twist is another feature found to influence the shape and openness of the 
aglycon basket (Figure 2B). Helical twist is assessed by defining an "axial ratio" of AR = 
length of the major axis/length of the minor axis. The axial ratio is a measure of the 
deformation of a ring system. An axial ratio close to one indicates that the ring system is 
nearly circular. The axial ratios for vancomycin are -1.3-1.7, for teicoplanin are -1.38-1.42, 
and for ristocetin A are -1.36-2.13. While none of the axial ratios approach one, teicoplanin 
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has the least deformed or strained aglycon basket and vancomycin and ristocetin A have the 
most deformed or strained aglycons [12]. 
Three of the macrocyclic glycopeptide molecules have several sugar moieties bonded 
to them. Vancomycin has a single disaccharide consisting of D-glucose and vancosamine. 
Ristocetin A has two monosaccharides and a tetrasaccharide that is composed of D-
arabinose, D-mannose, D-glucose, and D-rhamnose. Teicoplanin has three monosaccharides, 
two of which are D-glucosamine units and one is a D-mannose unit. One of the amine 
groups of teicoplanin's D-glucosamine is acetylated, and the amine of the other D-
glucosamine possesses a fatty acid chain. There are five related teicoplanin glycopeptides 
that differ only in the fatty acid chain bonded to the sugar group. The most common 
glycopeptide has an 8-methyl-nonoic acid chain. Because of the hydrophobic fatty acid 
chain and the ionizable groups on the aglycon portion of the molecule, teicoplanin is surface 
active, with a critical micelle concentration of 0.18 mM in unbuffered aqueous solutions [12]. 
The sugar groups of vancomycin and ristocetin A also possess ionizable amine groups that 
are usually protonated in the presence of aqueous and hydro-organic solvent mixtures; 
however, these two macrocyclic glycopeptides are not surface active. 
Being composed of both carbohydrates and amino acids, the macrocyclic 
glycopeptide antibiotics have abundant stereogenic centers. Ristocetin A has the largest 
number of stereogenic centers at 38, with teicoplanin and vancomycin having 23 and 18, 
respectively. Teicoplanin aglycon has eight stereogenic centers. The molecular masses of 
these compounds range from 1197 to 2066 g/mole. They are soluble in water and acidic 
aqueous solutions but are less soluble at neutral pHs [13]. Additionally, they are moderately 
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soluble in polar aprotic solvents such as DMSO and DMF but insoluble in most other organic 
solvents. 
The three macrocyclic glycopeptides function in vivo as antibiotics. Vancomycin 
binds to the cell wall of gram-positive bacteria and prevents cell wall growth, which 
eventually causes rupture and cell death. It was determined that vancomycin binds to D-
alanine-D-alanine groups present in the cell wall of gram-positive bacteria [7, 14, 15]. Given 
this strong binding to a chiral moiety, it was proposed that vancomycin and related 
compounds would make good chiral selectors. 
1.2.2 Macrocyclic Glycopeptides as Chiral Selectors for HPLC 
In 1994, macrocyclic glycopeptides were first introduced as chiral selectors for HPLC 
[4], Three different CSPs were produced with the macrocyclic glycopeptides vancomycin, 
rifamycin B, and thiostrepton bonded to silica supports. The three CSPs were evaluated in 
the reversed-phase mode and normal-phase mode. The most broadly applicable chiral 
selector was vancomycin, separating the enantiomers of 70 racemates. Only a few 
enantioseparations were reported for rifamycin B and thiostrepton. There were 45 
enantioseparations in the reversed-phase mode and 31 in the normal-phase mode. A large 
number of classes of compounds were analyzed, including derivatized amino acids, methyl 
esters, nitrogenous bases, hydantoins, and carboxylic acids. 
After the success of the vancomycin CSP, other similar macrocyclic glycopeptide 
antibiotics were evaluated. The antibiotic teicoplanin was immobilized on a silica support 
and evaluated as a chiral selector for HPLC [16]. In the reversed-phase mode, 99 
enantioseparations were reported, along with 29 enantioseparations in the polar organic mode 
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and 21 enantioseparations in the normal-phase mode. While there was a great variety in the 
functionalities and classes of the analytes, ~75% of the analytes that were separated in the 
reversed-phase mode contained carboxylic acid groups. Additionally, the authors noted the 
exceptional enantioselectivity of the teicoplanin CSP for native amino acids and peptides. 
This exceptional selectivity for amino acid-based analytes was further explored in the 
reversed-phase mode [17]. The study included all underivatized protenic amino acids, a 
large number of non-protenic amino acids, as well as several di-peptides. The effects of pH, 
buffer type and concentration, and organic modifier type and concentration were discussed. 
It was found that, for most of the compounds, no buffers or salts are required for the elution 
or enantioseparation of these compounds, allowing for easy isolation of the eluted 
enantiomers in preparative chromatography. The enantioselectivity of amino acids was 
found to be rather insensitive to small changes in pH, ionic strength, and organic modifier 
content. The naturally occurring L-enantiomer of all of the amino acids was eluted first, and 
the D-enantiomer was retained longer. The enantiomeric elution order of di-peptides was 
found to be more complicated. While often the D,D-dipeptides were more retained, there 
were a few cases where the L,D-dipeptides interacted more strongly with the teicoplanin 
chiral selector. 
The performance of a derivatized vancomycin CSP was evaluated in the three modes 
of HPLC [18]. Vancomycin was derivatized with either R- or 5-(l-napthylethyl)-isocyanate, 
yielding the corresponding carbamate. This derivative has proven to be effective at 
improving the performance of other CSPs [19-22], Additionally, the derivatizing agent is 
chiral and creates additional interaction sites for chiral recognition. The solid vancomycin 
CSP was exposed to a 10:1 molar ratio of the isocyanate (10 moles of isocyanate to 1 mole of 
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vancomycin on the surface of the silica), generating a randomly substituted chiral selector. 
Of the 60 compounds tested, 45% were separated on both derivatized and underivatized 
CSPs, 43% were separated on the derivatized CSP only, and 12% were separated on the 
underivatized CSP only. The compounds tested included: derivatized amino acids, 
hydantoins, alcohols, amino alcohols, methyl esters, and amines. Many of the separations 
that were obtained on both stationary phases were very similar. The most noticeable 
difference was the enantioseparation of dinitrobenzoyl-amino acids, which the derivatized 
phase was much better at separating. This improved chiral recognition was attributed to the x 
electron donor - n electron acceptor interactions between the dinitrobenzoyl groups on the 
amino acids and the napthyl groups of the derivatized CSP. Despite these improved 
enantioseparations, no further work on the derivatized vancomycin CSP has been found in 
the literature. 
The third macrocyclic glycopeptide that was found to be a broadly applicable CSP for 
HPLC is ristocetin A [23]. The chiral selector was bonded to silica gel and evaluated in the 
three modes of liquid chromatography with over 230 chiral analytes, including natural and 
unusual amino acids, derivatized amino acids, di- and tri-peptides, alcohols, amines, 
binapthyl compounds, nonsteroidal antiinflammatories, hydantoins, and amino alcohols. 
This CSP was shown to be complementary to the other macrocyclic glycopeptide CSPs; 
compounds that are partially separated into enantiomers by this CSP are often resolved by 
other macrocyclic glycopeptide CSPs. Similar to the teicoplanin CSP, the ristocetin A-based 
CSP has excellent enantioselectivity for native and derivatized amino acids and peptides. 
Unlike the teicoplanin-based CSP, there were a few cases where the naturally occurring L 
enantiomer of an amino acid was more retained than was the unnatural D enantiomer. This 
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change in the elution order of enantiomers was thought to be very desirable for analysis of 
"real-world" samples that are likely to contain a large excess of the L enantiomer. 
The final macrocyclic glycopeptide that has proven to be a useful chiral selector is 
teicoplanin aglycon [11]. This compound was produced by removing the sugar units from 
teicoplanin by acid hydrolysis. After purification, teicoplanin aglycon was covalently bound 
to a silica support by the same method as the other macrocyclic glycopeptides and evaluated 
chromatographically. The teicoplanin aglycon CSP was compared with a commercially 
available teicoplanin CSP, and the enantioselectivity of both columns for 26 compounds was 
assessed. The analytes included carboxylic acids, amines, hydantoins, amino alcohols, chiral 
ethers, and 13 amino acids. Both the teicoplanin and teicoplanin aglycon CSPs were 
effective at the enantioseparation of the amino acid analytes, with the teicoplanin aglycon 
CSP often producing greater enantioselectivity and chromatographic resolution. The authors 
attribute this to two factors: firstly the electrostatic interaction between the ionized amine 
group on both chiral selectors and the ionized carboxylic acid group of the analytes, and, 
secondly, access to the aglycon basket portion of the chiral selectors. The authors suggest 
that the sugar units of teicoplanin block access to the "basket" portion of the aglycon, which 
seems to be important for the chiral recognition of amino acids. Non amino acids 
compounds that possess carboxylic acid groups also interact with the ionized amine of the 
chiral selectors; however, there is no discernible trend regarding whether the sugar units of 
the chiral selector are beneficial or not (for the enantioseparation of these molecules). The 
neutral compounds and amine-containing compounds that do not possess an anionic group 
were generally better separated by the teicoplanin CSP, suggesting a mechanism of 
separation involving both the aglycon basket and the sugar units. While this was proposed as 
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a mechanistic study to evaluate the role of the sugar units of teicoplanin in enantioselectivity, 
the teicoplanin aglycon CSP was so successful that the stationary phase was developed into a 
commercial product. 
Since the introduction and commercialization of the macrocyclic glycopeptides 
vancomycin, teicoplanin, ristocetin A, and teicoplanin aglycon as chiral selectors for HPLC, 
there have been many applications of these CSPs to the enantiomeric separation of large 
groups of molecules. The enantioselectivity of these CSPs for a variety of chiral sulfoxides 
was examined by Berthod et al. [24]. Twenty-eight substituted dihydrofurocoumarins were 
analyzed by Xiao et al. [25]. The separation of unusual amino acids has been exhaustively 
covered by Peter et al. [26-41]. Additionally, Peter has also reported the enantioseparation of 
(3-lactam antibiotics [42] and 1,3-bicyclic-amino-alcohols [43]. There have been several 
studies that utilize the macrocyclic glycopeptide CSPs to analyze pharmaceuticals and their 
metabolites in biological fluids [44-50]. 
1.2.3 Mechanistic Studies on Macrocyclic Glycopeptide CSPs in HPLC 
The mechanism of enantioseparation by vancomycin was explored by capillary 
electrophoresis (CE) [51]. While this research is not conducted using liquid chromatography, 
the implications to the mechanism of enantioseparation warrant its inclusion in this review. 
It was found that vancomycin can form an easily isolatable complex of divalent copper, and 
x-ray crystallography indicated that the copper atom was coordinated with the amine group 
located on the aglycon portion of vancomycin (as opposed to the amine on the sugar group) 
[52]. The copper complex was generated in solution, isolated, and used in the run buffer of a 
CE experiment as the chiral selector. A large number of analytes were analyzed under 
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slightly acidic conditions, pH 6-7, (a condition where the vancomycin chiral selector is very 
effective for the analytes tested). No enantioseparations were observed at this condition. 
Similarly, no enantioseparations were observed at pH 9 with the vancomycin-copper 
complex. A lower pH of 5 was attempted, and 15 chiral carboxylic acids were partially 
separated. These compounds were much more effectively separated into enantiomers by the 
uncomplexed vancomycin. The authors concluded that the copper ion blocks a site on the 
vancomycin molecule that is critical for chiral recognition. Since the x-ray crystallography 
data indicated that the copper atom was complexed with the aglycon amine, it was clear that 
the electrostatic interactions between the amine and anions are critical in generating 
enantioselectivity. 
The complexation of teicoplanin with copper was also explored by HPLC [53]. A 
teicoplanin CSP was equilibrated with buffered mobile phases containing Cu2+, and the 
equilibration time was taken as a measure of the amount of copper adsorbed to the CSP. 
When 0.5 mM Cu2+ was in the mobile phase, 9 pmol of copper was estimated to be adsorbed 
to the stationary phase, corresponding roughly to one copper atom for every 45 teicoplanin 
molecules. When the concentration of copper was increased to 5.0 mM Cu2+ in the mobile 
phase, the amount of adsorbed copper increased to -50 |imol, corresponding to 
approximately one copper atom for every eight teicoplanin molecules. Clearly, this level of 
copper adsorbed to the stationary phase indicates that divalent copper did not form a strong 
1:1 complex with teicoplanin like it did with vancomycin. Chromatographic performance for 
amino acids was generally worse than with the uncomplexed teicoplanin CSP. While the 
ability of the copper complexed teicoplanin CSP to resolve the enantiomers of amino acids is 
reduced, and this is analogous to the results obtained from the vancomycin-copper complex, 
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the decrease in performance is attributed to the ability of amino acids to form a complex with 
copper in solution. The performance of the copper complexed CSP for neutral molecules 
was unpredictable, with some molecules being better separated by the copper complex CSP 
and some being better separated by the native teicoplanin CSP. 
This study also examined isotopic effects on enantioselectivity [53]. Teicoplanin has 
101 hydrogen atoms, 25 of which are exchangeable with deuterium, including the amide 
hydrogen atoms on the peptide chain, phenolic hydrogen atoms, hydroxyl hydrogen atoms on 
the sugar units, and the hydrogen atoms of the amine groups. Deuterated mobile phases were 
utilized to replace these hydrogen atoms. No salts, acids, or bases were used in the mobile 
phase for these experiments. The enantioseparations obtained with the partially deuterated 
teicoplanin CSP were largely unchanged from those obtained with the native teicoplanin 
CSP. Amino acids and other amine-containing compounds were retained less, and neutral 
compounds were retained more. Enantioselectivity was essentially unchanged. The authors 
attribute this to the isotopic effects changing the interactions between the chiral selector and 
enantiomers equally and therefore having no net effect on enantioselectivity. 
The mechanism of enantioseparation of two series of compounds was investigated in 
a series of papers by Lehotay and Armstrong et al. [54-58]. Both alkylamino derivatives of 
aryloxypropanols and alkoxy-substituted esters of phenylcarbamic acids were analyzed with 
teicoplanin and vancomycin CSPs in the polar organic mode [54]. Electrostatic interactions 
and hydrogen bonding contributed to enantioselectivity for these compounds in the polar 
organic mode, when it was previously believed that only hydrogen bonding was active in 
generating enantioselectivity in this mode. Subsequent papers focused on alkoxy-substituted 
esters of phenylcarbamic acids. The next publication in this series focused on method 
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development for the teicoplanin and teicoplanin aglycon CSPs in the polar organic mode and 
the role of the sugar units of teicoplanin in generating enantioselectivity [55]. The 
teicoplanin aglycon CSP was found to be more effective at resolving the enantiomers of these 
compounds. The authors concluded that structural groups that possessed great steric bulk 
that were in close proximity to the stereogenic center had a large impact on the separation of 
enantiomers, decreasing the degree of separation. 
The remaining papers in this series were thermodynamic van't Hoff studies on the 
teicoplanin aglycon CSP [56], an experimentally prepared methylated-teicoplanin CSP [57] 
and the vancomycin CSP and teicoplanin CSPs [58]. The compounds were eluted with polar 
organic mobile phases at temperatures varying between zero and 50°C. The plots of the 
natural log of the retention factor vs. the inverse of absolute temperature (van't Hoff plots) 
were linear across the selected range. The changes in enthalpy of transfer were always 
greater than the changes in entropy of transfer for these compounds in the polar organic 
mode. Additionally, the changes in enthalpy and entropy decreased with increasing aliphatic 
chain length. 
The four macrocyclic glycopeptides have proven to be versatile CSPs. They are 
multimodal stationary phases possessing good chromatographic efficiency and long-term 
stability. While there has been many applications developed utilizing these CSPs, there have 
been only a few studies on the mechanism of enantioseparation. This is primarily due to 
their relatively recent introduction and the overall difficulty in devising and carrying out 
definitive experiments that provide unambiguous mechanistic information. 
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Figure 1. Structure of a) teicoplanin b) teicoplanin aglycon c) vancomycin and d) ristocetin 
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a C: C C 
B C 
Figure 2. Simplified schematic showing two important morphological characteristics of the 
aglycon part of glycopeptide antibiotics. (A) End-to-end distance (represented by the length 
of the arrow) decreases from left to right. (B) The "C-shaped" aglycon also can be twisted to 
different degrees. The helical twist increases from left to right in this series of three figures. 
Reproduced with permission from reference 12. 
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CHAPTER 2 
The Manifestation of Charge Transfer Interactions and Ion-Dipole 
Interactions in the Linear Solvation Energy Relationship 
A paper submitted to Journal of Chromatography A 
Clifford R. Mitchell, Daniel W. Armstrong 
Abstract 
The linear solvation energy relationship (LSER) developed by Kamlet, Taft, and 
Abraham is utilized to characterize chromatographic stationary phases with varying aromatic 
and ionic character. One of the terms of this LSER method (the e-term) quantifies 
interactions through polarizable n and n electrons between a solute and a stationary phase. 
Such interactions are stronger in noripolar solvents and less significant in polar solvents. 
However, when using this LSER approach, several examples were found where certain 
stationary phases had larger e-terms in the reversed-phase mode (even on stationary phases 
with no n and n electrons) than in the normal-phase mode. We believe that this can be 
explained if the e-term encodes not only n/n and n/z interactions, but also ion-dipole 
interactions. This hypothesis was supported with experimental data from a divinylbenzene 
stationary phase that indicate that some n electron interaction does occur in the reversed-
phase mode and by data from an ion exchange stationary phase and a Primesep D cationic 
stationary phase indicates that ion-dipole interactions also occur in the reversed-phase mode. 
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It is demonstrated that both interactions are manifested in the e-term of the LSER and can be 
used to properly interpret retention results. 
2.1 Introduction 
One of the methods we are currently employing to study chiral stationary phases is 
the linear solvation energy relationship (LSER), developed by Abraham, Kamlet, and Taft. 
This method is able to deconvolute the intermolecular forces that contribute to retention. The 
relationship 
SP = c + eE + sS + a A + bB + vV 
equates a solute property (such as the logarithm of the partition coefficient) to the 
interactions the solute experiences between the two phases [1]. The variables E, S, A, B, and 
V are solute descriptors whose definitions are as follows. E is an excess molar refraction that 
is obtained from a compound's measured refractive index. S is the solute 
dipolarity/polarizability. A and B are the hydrogen bond acidity and basicity of a solute, 
respectively, and V is the McGowan volume (in cm3/100). The corresponding variables, c, e, 
s, a, b, and v, are system constants obtained by multiple linear regression analysis and are 
defined as follows. The e-term is the system's ability to interact through n and n electrons. 
The 5-term is the system's ability to interact via dipolar interactions. The a- and 6-terms are 
the system's hydrogen bond basicity and acidity, respectively (an acidic solute will interact 
with a basic phase), and the v-term is the system's ability to participate in dispersion 
interactions. The c-term contains the chromatographic phase ratio. This relationship has 
been used to describe liquid-liquid extraction [2], the uptake of drugs in intestinal absorption 
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[3] and oral absorption [4], the determination of water solubility [5], the determination of 
octanol-water partition coefficients [6], gas-liquid chromatography [7, 8], and HPLC [9-14]. 
During the course of these investigations, we have noted significant variability in the 
e-term, in the normal-phase mode and reversed-phase mode. Our initial interpretation of the 
interactions encoded by the e-term was n/71 and ji/tt stacking interactions. It is generally 
accepted that nAt and n/n interactions are more significant in nonpolar solvents (e.g., the 
normal-phase mode) and are diminished in more polar solvents (e.g., the reversed-phase 
mode) [15, 16]. However, our findings were inconsistent with our chemical intuition; that is, 
the measured e-term was indistinguishable from zero in the normal-phase mode (when n 
complexation should be relatively strong) and rather strong in the reversed-phase mode 
(when 7t complexation should be relatively weak). 
Upon re-examination of the seminal papers regarding LSER theory, Abraham 
indicates that the e-term only indicates interactions through polarizable n and n electrons. 
While this should obviously include n/% and n/n stacking interactions, it may also include 
ion-dipole interactions (since an ion can polarize n and n electrons). Consequently, the e-
term could be an indicator of the ionic character of a stationary phase. The goal of this 
research communication is to examine whether or not both n/n and n/n (aromatic character) 
and charge manifest themselves in the e-term when examining liquid chromatographic 
systems. 
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2.2 Experimental 
2.2.1 Materials 
HPLC grade acetonitrile, trifluoroacetic acid, and triethylamine were purchased from 
Fisher (Fairlawn, NJ). ACS grade potassium phosphate dibasic was purchased from Fisher. 
ACS grade potassium phosphate monobasic was purchased from EM Science (Darmstadt, 
Germany). HPLC grade water was obtained in house using reverse osmosis water filtered 
through an ion exchange resin. LSER probe molecules were purchased from Aldrich (St. 
Louis, MO) in high purity grade. The probe solutes are listed in Table I with their solute 
descriptors. 
The Primesep C and D HPLC columns were purchased from SiELC (Prospect 
Heights, IL) and were 0.46 x 5.0 cm. The Jordi Gel DVB RP 500A HPLC column was 
purchased from Alltech and was 0.46 x 15.0 cm. The Allsphere SAX column was purchased 
from Alltech and was 0.46 * 25.0 cm. The CIS HPLC column was purchased from ASTEC 
(Whippany, NJ) and was 0.46 x 5.0 cm. The Supelcosil LC-DP HPLC column was 
purchased from Supelco (Bellefonte, PA) and was 0.46 x 5.0 cm. All stationary phases were 
comprised of 5 ^m spherical particles. 
2.2.2 HPLC 
The HPLC system used consisted of a quaternary pump, an auto sampler, a UV VWD 
detector (1050, Hewlett Packard, Palo Alto, CA, USA), and an integrator (3395, Hewlett 
Packard). Mobile phases were prepared as volumetric ratios and degassed by a helium 
sparge. UV detection was carried out at 210 nm. All separations were carried out at room 
temperature (25°C). 
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2.2.3 Calculations 
Retention factors (k) were calculated using the equation k = (tr - tM)/tM- Multiple 
linear regression analysis and statistical calculations were performed using the program 
Analyse-it, an add in program for Microsoft Excel. 
2.3 Results and Discussion 
Several HPLC stationary phases of varying aromatic and ionic character were 
investigated using the LSER approach. The system constants for each system examined are 
listed in Table II. Mobile phases were composed of acetonitrile and water, and buffers or 
acids were used to promote ionization of the stationary phase where applicable. The mobile 
phase organic content to aqueous content ratio was selected to give a broad range of retention 
for the LSER probe solutes. Due to the wide variety in the retentiveness of these stationary 
phases, the stationary phases cannot be compared with each other at the same condition using 
the selected probe solutes. To make comparisons between the stationary phases at the same 
condition, the log kw of each solute was determined. The log kw is a simulated value of the 
log of the retention factor in a 100% aqueous mobile phase. It is determined for an 
individual solute by plotting several of the measured log k's versus the mobile phase 
composition and extrapolating to 0% organic solvent. The log kw is determined for each 
solute, and the correlation coefficients for these extrapolations were all 0.98 or better and 
frequently 0.99 or better. 
Figure 1 shows the system constants obtained for the different stationary phases at 
condition log kw. Clearly, there is a great deal of variation in all of the system constants for 
each system, which can be explained by considering the innate ability of each stationary 
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phase to participate in these interactions (or adsorb mobile phase solvents that can participate 
in these interactions). Figure 2 shows the e-terms from each system. There is also a great 
deal of variation in each system's ability to participate in the interactions encoded by the e-
term. 
The stationary phase with the weakest interactions based on the e-term is the C18 
stationary phase from Astec, which has an e-term of 0.12 at the condition log kw. The C18 
ligand is bonded to the silica support via a tri functional reagent, and the media is not end-
capped. This stationary phase does exhibit tailing when analyzing bases and must therefore 
have significant silanol activity. Furthermore, since the aqueous portion of the mobile phases 
used was phosphate buffer at pH 7.0, the silanol groups on the silica surface are 
predominantly ionized at the conditions used to character the stationary phase. As there are 
no 7t electrons available to interact with solutes and the n electrons that are available are 
located on ionized silanols, it is unlikely that the e-value of the CI8 stationary phase 
represents n/jt or 71/71 interaction but rather an ion-dipole interaction. Additionally, it is not 
unusual for alkyl ligand-based stationary phases to have an e-term that is zero or 
indistinguishable from zero [17]. 
The diphenyl stationary phase from Supelco has an e-term of 0.24 at condition log kw. 
This stationary phase is also a silica-based material and therefore a component of the e-term 
likely comes from ionized silanols on the silica surface. Additionally, the presence of the 
aromatic groups on the surface of the stationary phase creates the possibility for 71-electron 
interactions. The elevated e-value for this stationary phase, compared with the CI8, is likely 
due to this. 
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The Primesep D from SiELC has the next highest e-term of 0.36. This stationary 
phase consists of a C12 alkyl ligand bonded to a silica support, with an amine embedded in 
the €12 chain. The pKa of the amine is greater than 9 and is therefore ionized across the pH 
range at which the stationary phase is stable (0.5 - 4.0). The mobile phases used to 
characterize this stationary phase contained 0.1% trifluoroacetic acid. Given the absence of n 
and 7i electrons in the stationary phase and the presence of charged groups, both on the silica 
surface and in the alkyl chain, the interactions encoded by the e-term for this stationary phase 
must be the result of polarization of the n and % electrons on the analytes by the charged 
groups in the stationary phase. 
The Jordi Gel stationary phase has an e-term of 0.39 at condition log kw. The support 
of this stationary phase is composed of divinylbenzene, contains no ligands, and is free of 
silica or other ionizable compounds. In this case, the e-term for this stationary phase can 
only be due to ^-electron interactions. 
The stationary phase with the largest e-term, 0.52, is the Allsphere SAX. The system 
constants for this stationary phase were obtained at 5/95 acetonitrile/30 mM phosphate buffer 
pH 5.0. The retention of the probe solutes was extremely weak with mobile phases with 
larger amounts of acetonitrile, and most probe solutes did not elute with a 100% aqueous 
mobile phase. The stationary phase consists of a trimethyl-propyl-ammonium ligand bonded 
to a silica support. Clearly, there is a large amount of charge on the surface of this media 
from the trimethyl-propyl-ammonium group, as well as ionized silanols. The lack of n 
electrons on the stationary phase and the large amount of charge on the surface suggest that 
the interaction encoded by the e-term is an ion-dipole interaction. 
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While 7r-electron complexation and ion-dipole interactions seem to be intermixed in 
the e-term, consideration of the composition of the stationary phase can indicate what type of 
interactions are occurring in the system. If a stationary phase is devoid of n electrons and has 
ionizable residues, the e-term most likely indicates ion-dipole interactions. Conversely, if a 
stationary phase contains no ionizable groups and there are it electrons present, the e-term is 
likely indicative of n complexation. In the normal-phase mode, the e-term is most likely an 
indication of K complexation because ions are poorly solvated by normal-phase solvents and 
any fixed charges in the stationary phase (such as quaternary amines) would exist as an ion 
pair with a counter-ion. 
2.4 Conclusions 
While the e-term is a rather weak component of retention in the reversed-phase mode, 
it encodes two different types of interactions: ^-electron complexation and ion-dipole. 
Despite the rather weak interaction strength of ^-electron complexation in the reversed-phase 
mode, the data obtained from the divinylbenzene stationary phase indicates that ^-electron 
complexation does occur in this mode. However, the data obtained from other stationary 
phases that contain ionized groups and no ^-electrons indicate that there must also be some 
ion dipole interaction encoded in the e-term of the LSER. 
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Figure 1. System constants for the stationary phases in this study at log Kw. DP -
Supelcosil LC-DP diphenyl column, DVB - Jordi Gel DVB RP divinylbenzene, SAX -
Alltech Allsphere anion exchange column, ODS - CI8 column from Astec, Primesep D -
mixed mode C12/anion exchange from SiELC. 
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Figure 2. e-term system constants for the stationary phases in this study. Column 
designations are the same as in Figure 1. 
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Table L Probe solutes and their solute descriptors. 
Ea S A B V 
1,3,5-trihydroxybenzene 1.355 1.12 1.40 0.82 0.8925 
1,3-benzenediol 0.980 1.00 1.10 0.58 0.8338 
1-nitrobutane 0.227 0.95 0.00 0.29 0.8464 
4-ethylphenol 0.800 0.90 0.55 0.36 1.0569 
3-cyanophenol 0.930 1.55 0.77 0.28 0.9300 
benzonitrile 0.742 1.11 0.00 0.33 0.8711 
acetophenone 0.818 1.01 0.00 0.48 1.0139 
phenol 0.805 0.89 0.60 0.31 0.7751 
2-nitrophenol 1.015 1.05 0.05 0.37 0.9490 
1-nitropentane 0.212 0.95 0.00 0.29 0.9873 
o-cresol 0.840 0.86 0.52 0.30 0.9160 
m-cresol 0.822 0.88 0.57 0.34 0.9160 
p-cresol 0.820 0.87 0.57 0.31 0.9160 
methyl-4-hydroxybenzoate 0.900 1.37 0.69 0.45 1.1313 
nitrobenzene 0.871 1.11 0.00 0.28 0.8906 
n-ethyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.2722 
1-nitrohexane 0.203 0.95 0.00 0.29 1.1282 
benzene 0.610 0.52 0.00 0.14 0.7164 
4-nitrotoluene 0.870 1.11 0.00 0.28 1.0315 
m-trifluoromethylphenol 0.425 0.87 0.72 0.09 0.9691 
n-propyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.4131 
4-chlorophenol 0.915 1.08 0.67 0.20 0.8970 
toluene 0.601 0.52 0.00 0.14 0.8573 
o-xylene 0.663 0.56 0.00 0.16 0.9982 
m-xylene 0.623 0.52 0.00 0.16 0.9982 
p-xylene 0.613 0.52 0.00 0.16 0.9982 
3-chlorophenol 0.909 1.06 0.69 0.15 0.8970 
valerophenone 0.800 0.95 0.00 0.50 1.4370 
n-butyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.5540 
1-naphthol 1.520 1.05 0.61 0.37 1.1441 
benzophenone 1.447 1.50 0.00 0.50 1.4808 
ethylbenzene 0.613 0.51 0.00 0.15 0.9980 
3,4-dichlorophenol 1.020 1.14 0.85 0.03 1.0199 
naphthalene 1.340 0.92 0.00 0.20 1.0854 
hexanophenone 0.720 0.95 0.00 0.50 1.5780 
heptanophenone 0.720 0.95 0.00 0.50 1.7180 
n-propylbenzene 0.604 0.50 0.00 0.15 1.1391 
dibenzo thiophene 1.959 1.31 0.00 0.20 1.3791 
biphenyl 1.360 0.99 0.00 0.22 1.3242 
n-buytlbenzene 0.600 0.51 0.00 0.15 1.2800 
anthracene 2.290 1.34 0.00 0.26 1.4544 
phenanthrene 2.055 1.29 0.00 0.26 1.4544 
pyrene 2.808 1.71 0.00 0.28 1.5846 
a) E, S, A, B, and V are the solute descriptors, defined in the experimental section of the text 
Table II. System constants in the reversed-phase mode for the various stationary phases studied. Stationary phase designations 
are the same as those from Figure 1. r2 is the coefficient of correlation, SE is the standard error of regression, F is the Fisher 
statistic, n is the number of solutes in the regression. 
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 CO 
MPb e s a b V c r2 SE F n 
ODS 60% ACN 0.1170 -0.3789 -0.6076 -1.4019 1.2868 -0.2247 0.99 0.0471 796.6 41 
ODS 50% ACN 0.1071 -0.3839 -0.6456 -1.6516 1.4941 -0.0774 0.99 0.0590 838.2 42 
ODS 40% ACN 0.1771 -0.5334 -0.6266 -1.6732 1.7437 0.0881 0.99 0.0737 636.5 42 
ODS 30% ACN 0.1958 -0.6369 -0.6311 -1.8345 2.0506 0.3068 0.98 0.0817 399.1 33 
ODS L Kw ACN 0.1239 -0.5322 -0.8421 -3.0424 2.8593 0.5963 0.98 0.1012 478.8 40 
Buffer: phosphate pH 7.0 20mM 
DP 40% ACN 0.0431 -0.1374 -0.4694 -1.4438 1.2084 -0.5293 0.99 0.0544 588.2 42 
DP 35% ACN 0.0706 -0.1853 -0.4591 -1.5152 1.3599 -0.4951 0.99 0.0535 699.8 42 
DP 30% ACN 0.1114 -0.2417 -0.4347 -1.5795 1.5469 -0.4851 0.99 0.0538 808.7 43 
DP 10% ACN 0.2459 -0.2374 -0.3028 -1.9566 2.4546 -0.9049 0.99 0.0643 412.4 31 
DP L Kw ACN 0.2366 -0.4213 -0.2470 -2.1803 3.0270 -0.9268 0.99 0.0998 592.9 43 
PrimeD 40% ACN 0.0505 -0.0731 -0.1766 -1.6248 1.3039 -0.4778 0.99 0.0477 615.0 42 
PrimeD 35% ACN 0.0824 -0.1245 -0.1724 -1.7327 1.4737 -0.4493 0.99 0.0480 745.8 42 
PrimeD 30% ACN 0.1241 -0.1848 -0.1398 -1.8268 1.6643 -0.4092 0.99 0.0512 785.5 42 
PrimeD 10% ACN 0.1729 -0.2217 -0.0831 -2.0006 1.8741 -0.4857 0.99 0.0595 548.8 39 
PrimeD L Kw ACN 0.3572 -0.5271 0.0513 -2.6150 2.9643 -0.5239 0.98 0.1090 463.4 43 
Buffer: phosphoric acid pH 2.2 
DVB 70% ACN 0.4823 -0.3838 -0.7487 -1.1905 1.0275 -0.0728 0.99 0.0510 963.5 41 
DVB 60% ACN 0.4506 -0.4368 -0.7676 -1.2905 1.1855 0.0884 0.99 0.0570 634.3 39 
DVB 50% ACN 0.4322 -0.4456 -0.7885 -1.4783 1.3008 0.3114 0.98 0.0640 372.8 33 
DVB L Kw ACN 0.3904 -0.5888 -0.9450 -2.1469 2.1004 1.0791 0.97 0.1287 274.5 39 
SAX 5% ACN 0.5199 -0.5655 -0.4694 -1.1745 1.7260 -1.7545 0.94 0.1232 112.0 34 
Buffer: phosphate pH 5.0 
i) SP - stationary phase, b) MP -mobile phase 
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CHAPTER 3 
Characterization of Macrocyclic Glycopeptide-Based Stationary Phases 
with a Linear Solvation Energy Relationship 
A paper submitted to Journal of Chromatography A 
Clifford R. Mitchell, Daniel W. Armstrong 
Abstract 
The mechanism of retention for four commercially available macrocyclic glycopeptide chiral 
stationary phases was investigated using a linear solvation energy relationship (LSER) in the 
reversed-phase mode and the normal-phase mode. The LSER approach is very successful at 
describing the factors that lead to retention on these stationary phases. The retention data 
yield excellent statistical fits (correlation coefficients, r2, greater than 0.98). The differences 
in the retention mechanism between the two modes of operation on the same stationary phase 
are easily differentiated by using the LSER. In the reversed-phase mode, the macrocyclic 
glycopeptide CSPs have significantly different hydrogen bond acidity, basicity, and dipolar 
system constants compared with octadecyl silane stationary phases. The change in value of 
these system constants upon changing mobile phase conditions is also significantly different 
from the system constants of octadecyl silane stationary phases. Retention in the reversed-
phase mode was found to be governed by dispersive/hydrophobic interactions, dipolar 
interactions, and n and n electron interactions. In the normal-phase mode, the system 
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constants were similar to other conventional normal-phase stationary phases. Retention was 
found to be governed by hydrogen bonding and dipolar interactions. 
3.1 Introduction 
Macrocyclic glycopeptide based chiral stationary phases (CSPs) have proven to be 
extremely useful in enantiomeric separations and are one of the fastest growing classes of 
CSPs today [1-4]. They have exceptional selectivity for amino acids [5, 6], and have proven 
to be useful for the enantiomeric separation of a wide variety of molecules [7], Chemically, 
they are composed of a diversity of functional groups (Figure 1), including hydroxyls, 
phenols, amides, aromatic rings, various carbohydrate moieties, ionizable carboxylic acid, 
and amine groups, as well as a basket-shaped structure [8], This plethora of functional 
groups is a stark contrast to the hydrocarbon chains of which the majority of conventional 
reversed-phase stationary phases are composed. Due to these structural differences, 
macrocyclic glycopeptide-based stationary phases are capable of participating in a greater 
variety of intermolecular interactions compared with a conventional brush type stationary 
phase and can be considered an "alternate selectivity" type of reversed-phase stationary 
phase. In addition to the differences observed in reversed-phase HPLC, macrocyclic 
glycopeptide CSPs are effective in the normal-phase mode and polar organic mode and the 
mechanism of retention and separation is different in each mode of operation [7], However, 
no quantitative physicochemical data have been published that supports the assumed 
differences in retention mechanisms when the same stationary phase is used in the reversed-
phase mode versus the normal-phase mode. 
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It is desirable to be able to describe any stationary phase with objective 
physicochemical parameters. An objective description of stationary phases would allow the 
analyst to determine if stationary phases from different manufacturers are nominally 
equivalent, somewhat similar, or orthogonal. This is especially useful in today's laboratory 
where there are over 600 different reversed-phase stationary phases available to the analyst, 
with new and improved products being added all the time [9, 10]. 
There have been many systems and tests devised to evaluate the physical and 
chemical properties, as well as the performance, selectivity, and efficiency of 
chromatographic stationary phases [11-19]. They range in complexity from the rather 
elegant yet simple tests proposed by Walters [11] and Tanaka [12] to more complicated 
methods involving spectroscopic analysis [20-22], physical measurements [23], and 
statistical analyses [24-28], Many of the simple tests, purported to indicate silanol activity, 
hydrophobicity, and hydrogen bond capacity, can give results that vary significantly [17]. 
Often, columns that would be ranked as having low silanol activity by one test are ranked 
higher when another test procedure is used [15]. 
The application of these tests to CSPs can give misleading results. It seems that there 
is a general presumption that, when these types of tests are applied to a typical CI 8 stationary 
phase, it is desirable to have low silanol activities and low hydrogen bond capacities. Of 
course, for a conventional reversed-phase column, this is correct. But in the application of 
these tests to a CSP (which will most assuredly contain hydrogen bonding groups as part of 
the chiral selector and could contain ionizable groups as well), the hydrogen bond capacity 
and silanol activity will be elevated. In this case, the tests are not necessarily flawed, but it 
must be understood why the results are elevated. 
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The physical properties that are most frequently cited as being indicative of the 
quality of a stationary phase are: percent carbon loading, surface area, pore volume and size, 
and ligand density. These parameters are usually determined by the manufacturer, as they 
are valuable information for quality control in the manufacturing process [16]. 
Unfortunately, there is often poor correlation between these parameters and chromatographic 
performance. The same can be said of spectral measurements made on bulk stationary 
phases. The data obtained are complex, and there is no clear relation between the data and 
chromatographic performance. Furthermore, techniques such as solid state NMR are time 
consuming and are often cost prohibitive. 
One of the more comprehensive and broadly applicable systems for the 
characterization of biphasic systems is the linear solvation energy relationship (LSER) 
developed by Abraham [26]. It is used to characterize systems by interrogating them with 
well characterized probe solutes. Information about the system (in terms of defined system 
constants) is gleaned through linear regression. LSERs have been applied to liquid-liquid 
extraction [29], the uptake of drugs in intestinal absorption [30] and oral absorption [31], the 
determination of water solubility [32], the determination of octanol-water partition 
coefficients [33], gas-liquid chromatography [34, 35]. Abraham and Carr have conducted 
extensive studies in high performance liquid chromatography [36-41]. The relationship, 
expressed mathematically, is 
SP = c + eE + s8 + aA + bB + vV 
where SP is a solute property, such as the logarithm of partition coefficient or retention 
factor. The variables E, S, A, B, and V are solute descriptors whose definitions are as 
follows. E is an excess molar refraction that is obtained from a compound's measured 
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refractive index. S is the solute dipolarity/polarizability. A and B are the hydrogen bond 
acidity and basicity of a solute, respectively, and V is the McGowan volume (in cm3/100) 
that can be easily calculated with knowledge of a solutes molecular structure and the 
appropriate constants for the constituent atoms [42]. 
The coefficients, c, e, s, a, b, and v, are obtained by linear regression. They are 
characteristic of the particular system that is described by the SP parameter, and they indicate 
the relative difference in the strength of a particular interaction a solute experiences between 
two phases, e reflects the system's ability to interact with a solute through n- and n- electron 
pairs, s is a measure of the system's ability to participate in dipolar interactions, a is the 
hydrogen bond basicity of the system, and b is the hydrogen bond acidity of the system (an 
acidic solute will interact with a basic phase/system), v is a measure of the system's ability 
to participate in dispersion interactions and c is the phase ratio of the system. The sign of the 
fitting coefficients indicates which phase dominates in a particular interaction—positive 
indicating the stationary phase and negative for the mobile phase. 
In this article, we will focus on the characterization of macrocyclic glycopeptide-
based CSPs by Abraham's LSER in the reversed-phase mode and normal-phase mode. As 
previously mentioned, the mechanism of retention and selectivity is said to change with the 
mode of operation. These changes in mechanism should be reflected by the system constants 
obtained from LSER analysis. It should be noted that this approach is applicable to any CSP 
or chiral selector. 
Some care must be taken when selecting a group of probe solutes to interrogate a 
CSP. The primary concern should be which mode of operation will be characterized by the 
LSER theory. Macrocyclic glycopeptide CSPs are multi-modal stationary phases, which can 
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separate enantiomers in the reversed-phase mode, the normal-phase mode, and the polar 
organic mode. While there have been many studies utilizing Abrahams LSER theory in the 
reversed-phase mode, there have been few studies conducted in the normal-phase mode [43-
46] and none in the polar organic mode. Additionally, the limited normal-phase studies have 
used the same probe solutes popularized in the reversed-phase studies. While not strictly 
inappropriate, many of the probe solutes from these reversed-phase studies are not 
appreciably retained even in the weakest normal-phase conditions. Because it is generally 
desirable to have both appreciable retention and a range of retention for the probe solutes, 
judicious selection of the probe solutes is critical with respect to the mode of operation (see 
experimental). 
3.2 Experimental 
3.2.1 Materials 
The CSPs were obtained from Advanced Separation Technologies (Whippany, NJ). 
All stationary phases used consisted of the chiral selector bonded to 5-jj.m spherical silica gel. 
The chiral selectors used are the macrocyclic glycopeptide, which are shown in Figure 1. 
The dimensions of the columns are 50 x 4.6 mm. 
Methanol, acetonitrile, heptane, ethanol, and isopropanol were HPLC grade from 
Fisher (Fairlawn, NJ). All LSER probe solutes were obtained from Aldrich (St. Louis, MO) 
in high purity grade (99% or greater). It is desirable to utilize a large number of probe 
solutes for redundancy in each determination. In this study, we have selected 38 compounds 
for the reversed-phase mode (Table 1) and 51 compounds for the normal-phase mode (Table 
2). The probe solute sets contain a diversity of functionalities. Our sets of probe solutes 
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contain aldehydes, ketones, amides, halogenated phenols, nitro substituted benzenes, nitro 
substituted alkanes, alkyl benzenes, and polyaromatic hydrocarbons. Care was taken to 
exclude solutes that interact with the chiral selectors in a manner inconsistent with the 
majority of the probe solutes (i.e., strongly silanophilic compounds). Additionally, the 
molecular descriptors span a wide range and do not show large intercorrelation (Tables 3 and 
4). 
3.2.2 Instrumental 
The HPLC system used consisted of a quaternary pump, an auto sampler, a UV VWD 
detector (1050, Hewlett Packard, Palo Alto, CA, USA), and an integrator (3395, Hewlett 
Packard). Mobile phases were degassed by ultra-sonication under vacuum for 5 minutes. 
UV detection was carried out at 210 nm. All separations were carried out at room 
temperature (25°C). 
3.2.3 Column Evaluation 
The retention factor of each probe solute was obtained on each stationary phase in the 
reversed-phase mode using acetonitrile/water and methanol/water mobile phases. In the 
normal-phase mode, each stationary phase was evaluated with ethanol/heptane mobile 
phases. The flow rate was set at 1.0 mL-min"1. The column dead time (tw) was determined 
in the reversed-phase mode by the negative peak observed upon injection of 25 pU of 
deuterium oxide and, in the normal-phase mode, by the retention time of tri t-butyl benzene. 
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3.2.4 Calculations 
Retention factors (k) were calculated using the equation k = (tr - ImVIm- Multiple 
linear regression analysis and statistical calculations were performed using the program 
Analyse-it, an add in program for Microsoft Excel. 
3.3 Results and Discussion 
The four commercially available macrocyclic glycopeptide CSPs were evaluated in 
the reversed-phase mode using acetonitrile/water and methanol/water based mobile phases at 
a variety of conditions. The normal-phase mode also was evaluated using ethanol/heptane 
mobile phases at a variety of conditions. The retention factor of the probe solutes was 
obtained at each condition. LSER fitting coefficients were obtained from these retention data 
by multiple linear regression analysis. The correlation coefficients were 0.99 and 0.98, and 
the standard errors were about 0.04 and 0.10 in the reversed-phase mode and normal-phase 
mode, respectively. Additionally, the LSER equations were determined for the CSPs using 
log kw (the logarithm of the retention factor in 100% water). This allows objective 
comparisons to be made independently of the mobile phase composition [47]. Log kw was 
determined by extrapolation of log k data to 0% organic modifier in the mobile phase. 
Similarly, LSER equations were determined for the CSPs using log khep, simulating retention 
in a 100% heptane mobile phase. The correlation coefficient for these extrapolations was 
0.98 or better. Log kw was determined for both methanol- and acetonitrile-based mobile 
phases and designated log kw MeOH and log kw ACN. In principle, log kw should be 
independent of the organic modifier and the values extrapolated from methanol/water 
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retention data should be equal to the values extrapolated from acetonitrile/water retention 
data. It has been observed from CI8 retention data that the extrapolated log kw retention 
factor of a compound can differ depending on the identity of the organic modifier [27, 48]. 
The properties of the organic modifier must have some residual influence on the 
determination of log kw, and this influence is manifest in the value of log kw for a given probe 
solute and the magnitude of the LSER system constants derived from the retention of these 
probe solutes. The magnitude of these differences on the macrocyclic glycopeptide CSPs is 
not as great as those observed on CI8 stationary phases and will be noted in the discussion 
below. 
3.3.1 LSER Results in the Reversed-Phase Mode 
The coefficients from the LSER equations obtained in the reversed-phase mode are 
presented in Tables 5 and 6. The general features found in the data reflect the same general 
trends shown by achiral reversed-phase systems, i.e., a large positive v-term 
(hydrophobicity), a large negative 6-term (hydrogen bonding in the mobile phase), and a 
nonzero, negative a-term (hydrogen bonding in the mobile phase). Additionally, the e-term 
(n and n electron interaction) is nonzero and positive. 
When making specific comparisons of the coefficients obtained at log kw (Table 5), 
there are significant differences between CI8 stationary phases and macrocyclic glycopeptide 
CSPs. The sign and magnitude of the s-term (dipolarity) for the macrocyclic glycopeptide 
CSPs is different from a CI8 column (0.30 for Chirobiotic T and -0.79 for CIS). Obviously, 
this occurs because of the presence of polar functional groups in the macrocyclic 
glycopeptide (e.g., hydroxy!, amido, amino, etc). Furthermore, the stationary phase contains 
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sorbed mobile phase solvent molecules. It is well established that CIS stationary phases 
contain an enriched ratio of organic modifier to water compared with the mobile phase 
composition, and that the ratio of solvents in the stationary phase is relatively constant over 
most of the range of mobile phase compositions [49-52]. Because macrocyclic glycopeptides 
are much more polar than octadecyl alkyl chains, the macrocyclic glycopeptide CSPs will 
likely contain a higher proportion of the polar component of the mobile phase mixture. 
Water, a very polar compound having a dipolarity of 1.09, will influence the dipolarity of the 
stationary phase when sorbed. The s-term in this case is likely elevated, compared with the 
CIS column, because of the intrinsically more polar macrocyclic glycopeptides and of the 
sorbed mobile phase solvents. 
The magnitude of the v-, b-, and a-terms are quite different between CIS and 
macrocyclic glycopeptide CSPs. The v-term is much larger for the CIS stationary phase 
(4.65 vs. 1.49 for the Chirobiotic T CSP). This larger v-term is easily rationalized 
considering that a CIS stationary phase is much more hydrophobic. The 6-term (hydrogen 
bond acidity of the stationary phase) is elevated for the macrocyclic glycopeptide CSPs (-
0.46 and -3.19 for Chirobiotic T and CIS, respectively). This difference in the 6-terms of 
these two stationary phases can again be rationalized by the presence of polar groups that can 
participate in hydrogen bonding and the presence of sorbed mobile phase solvents. The 
macrocyclic glycopeptide molecules contain native polar hydrogen bonding groups, whereas 
an octadecyl chain contains no hydrogen bond acceptor moieties. Additionally, organic 
modifiers such as acetonitrile and methanol are weak hydrogen bond acids (0.07 and 0.43, 
respectively) and will not significantly raise hydrogen bond acidity of the octadecyl 
stationary phase in which they are sorbed. Water is an extremely strong hydrogen bonding 
46 
acid (1.17), and the increased amount of water in the macrocyclic glycopeptide stationary 
phase has a pronounced effect on the 6-term. 
Compared with the other LSER parameters, the a-term (hydrogen bond basicity of the 
stationary phase) exhibits a greater amount of variation, at the condition log kw, based on the 
identity of the organic modifier. When methanol was used as the organic modifier, the C18 
stationary phase had a higher a-term compared with the macrocyclic glycopeptide CSPs. 
However, when acetonitrile was used as the organic modifier, the a-term was lower for the 
C18 stationary phase, and was comparable with the macrocyclic glycopeptide CSPs. These 
differences are due to hydrogen bonding bases in the stationary phase (or lack thereof), as 
well as mobile phase molecules sorbed to the stationary phase. Acetonitrile and methanol 
have moderate hydrogen bond basicities (0.32 and 0.47, respectively). The higher hydrogen 
bond basicity of the stationary phase observed in the methanol data must be influenced by 
this difference. 
Recently, we conducted a study investigating the type of interactions that manifest 
themselves in the e-term [53]. We concluded that both n electron complexation and ion-
dipole interactions, both of which are interactions involving n and n electrons, are encoded in 
the e-term. The e-term is positive for the CI8 and the macrocyclic glycopeptide CSPs and 
generally the e-term for the macrocyclic glycopeptide CSPs can be similar to the CI8 column 
(0.24 for Chirobiotic T and 0.29 for CI8) or significantly larger (0.78 for Chirobiotic R). It 
seems likely that both of the e-terms for these two classes of stationary phases are due to the 
presence of ionized groups, which are both on the silica surface and on the chiral selectors. 
Foremost, TC complexation is a relatively weak interaction in the reversed-phase mode of 
operation. Additionally, the C18 alkyl chain has no n electrons for n complexation. While 
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there are many n electrons on the macrocyclic glycopeptides, the normal-phase results, 
discussed below, seem to indicate that these stationary phases are not strong n complexation 
stationary phases. For these reasons, we attribute the interactions accounted for in the e-term 
in the reversed-phase mode as ion-dipole interactions. 
When the composition of the mobile phase is changed, the system constants of the 
macrocyclic glycopeptide CSPs change as well. Some of the terms exhibit changes 
consistent with classical reversed-phase behavior, that is, the absolute value of the terms 
increases as the mobile phase becomes more polar; other terms exhibit more unusual trends 
as the composition of the mobile phase changes (Fig. 2 and 3, Table 6). For example, as the 
amount of water in the mobile phase increases, the v-term (hydrophobicity) for Chirobiotic T 
is positive and increases in magnitude, which is in agreement with classic reversed-phase 
behavior. Interestingly, several of the system constants for the macrocyclic glycopeptide 
CSPs exhibit trends that conventional stationary phases do not. The e-, s-, and a-terms are 
essent ia l ly  cons tant  for  the  CIS column (Fig .  4 ) .  The  smal l  changes  in  the  s - te rm for  the  CIS 
column, with changing mobile phase composition, are in the negative direction. Conversely, 
the e- and 5-term for the macrocyclic glycopeptide CSPs become more positive and the sign 
of the 5-term is the opposite of the 5-term for the CIS column (as mentioned above). 
Additionally, the 6-term, which is negative in sign, becomes slightly more positive in several 
cases (the opposite of what is seen on CIS) and the a-term becomes more negative. 
These changes are due to both the changing ratio of water to organic modifier in the 
mobile phase and the changing amount of water and organic modifier that is sorbed to the 
stationary phase. The changes in the mobile phase likely have a greater impact on the 
magnitude of the system constants. As the composition of the mobile phase shifts to more 
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water, the ability of the mobile phase to participate in hydrogen bonding and dipolar 
interactions changes, and the values of the system constants shift to reflect these changes. 
Additionally, there are changes in the amount and ratio of sorbed mobile phase solvents. In 
the case of the a-term, as the amount of organic modifier in the mobile phase decreases, it is 
likely that the amount of organic modifier sorbed to the stationary phase changes as well. 
Since these solvent molecules are moderate hydrogen bond bases, decreasing their 
concentration in the stationary phase decreases the basicity of the stationary phase (a-term). 
Likewise for the 6-term and s-term, as the amount of water in the mobile phase increases, the 
relative amount of water sorbed to the stationary phase increases. Because water is a strong 
hydrogen bonding acid, and very polar, increasing the amount of water absorbed to the 
stationary phase will increase the acidity of the stationary phase (6-term) and dipolarity of the 
stationary phase (5-term). The e-term generally decreases in magnitude with the addition of 
organic modifier. These changes are likely due to the changing amount of organic solvents 
in the system as well as changes in the ionized state of the charged groups on the chiral 
selector. It is well established that the ionization constants for acids and bases will shift in 
the presence of organic solvents (which possess different dielectric constants) [54]. The pKs 
of the carboxylic acid and amine on the teicoplanin molecule in solution are 2.5 and 9.2, 
respectively [6]. Slight shifts in the ionization pKs of these groups can decrease the number 
of charged sites on the chiral selector, thereby reducing the number of ion-dipole interactions 
and decreasing the value of the e-term. 
These macrocyclic glycopeptide CSPs can also be compared with each other, at the 
condition log kw, to determine which is the most hydrophobic or dipolar or hydrogen bond 
acidic. Figure 5 shows the system constants for these CSPs at log kw MeOH and log kw 
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ACN. While there are some differences in the system constants between these conditions, 
the ranking of these CSPs is largely unaffected, unless noted. From Figure 5, it is clear that 
the Chirobiotic TAG is the most hydrophobic of the examined CSPs, followed by the 
Chirobiotic T, Chirobiotic R, and Chirobiotic V. Additionally, the Chirobiotic TAG and R 
are the least H-bond acidic CSPs, while the Chirobiotic T is the most H-bond acidic CSP. 
There is some variation between the methanol based 6-term and acetonitrile based 6-term for 
the Chirobiotic V phase. The CSP capable of the strongest n and n electron interactions is 
the Chirobiotic R, which is followed by the Chirobiotic TAG. Chirobiotic T and V are 
nominally equivalent in this regard. The Chirobiotic R is also the most dipolar phase, with 
the other 3 having similar s-terms (although there is some variation between the methanol 
and acetonitrile system constants). Finally, the Chirobiotic R is the least H-bonding basic 
phase, followed by the Chirobiotic T, with Chirobiotic V and TAG being nominally 
equivalent. These differences between the macrocyclic glycopeptide CSPs at condition log 
kw reflect the chemical composition differences between the four chiral selector molecules. 
3.3.2 LSER Results in the Normal-phase Mode 
The system constants obtained for these macrocyclic glycopeptide CSPs in the 
normal-phase mode are presented in Tables 7 and 8. The general features are similar to other 
normal-phase systems described in the literature, i.e., large and positive 5-, a-, and 6-terms, 
negative v-terms, and statistically insignificant e-terms [43-45]. Furthermore, the magnitude 
of the system constants for the macrocyclic glycopeptide CSPs are similar to conventional 
stationary phases (bare silica, amino, diol, and cyano phases), although there is a great deal 
50 
of variation in the system constants between the different types of conventional stationary 
phases. 
At condition log khep, the differences in the polar system constants of the four 
macrocyclic glycopeptide CSPs are readily determined (Figure 6, Table 7). The Chirobiotic 
TAG is the most H-bond acidic phase (6-term), whereas the Chirobiotic V is the least. The 
Chirobiotic T and Chirobiotic R phases are indistinguishable in this regard. Additionally, the 
macrocyclic glycopeptide CSPs have nearly identically H-bond basicity (a-term). The most 
dipolar phase is the Chirobiotic V; whereas the Chirobiotic T, TAG, and R are have very 
similar s-terms. 
When the composition of the mobile phase changes, the system constants of the 
macrocyclic glycopeptide CSPs change in a manner consistent with normal-phase systems; 
that is, when the mobile phase becomes less polar, the magnitude of the system constants 
increase (Figure 7, Table 8). The trend observed in the v-term is due to the change in the 
solvent properties of the mobile phase. As the amount of heptane in the mobile phase 
increases, the v-term decreases. Because heptane is only capable of dispersive intermolecular 
interactions, an increase of heptane content in the mobile phase will increase the ability of the 
mobile phase to participate in dispersive interactions, relative to the stationary phase. 
The trends in the s-, a-, and 6-terms are also due to the changing mobile phase 
conditions. The stationary phase is relatively polar, and the polar modifier molecules will 
interact strongly with the adsorption sites of the stationary phase. As the amount of polar 
modifier in the mobile phase decreases, fewer adsorption sites of the station phase are 
occupied by the polar solvent molecules and are available to interact with solutes. 
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Consequently, the hydrogen bond acidity, hydrogen bond basicity, and dipolarity of the 
stationary phase increase. 
The e-terms I measured for all macrocyclic glycopeptide CSPs in the normal-phase 
mode were indistinguishable from zero. Many conventional normal-phase stationary phases 
(silica, amino, cyano) often have e-terms that are zero [43-46]. However, these stationary 
phases do not have aromatic functionalities and are not thought to operate as n electron 
association stationary phases. Conversely, the macrocyclic glycopeptide CSPs do contain 
many aromatic residues, as well as carbonyl groups and nonbonding electrons, and it has 
been proposed that n electron complexation is an interaction that contributes to retention and 
selectivity [7]. These data suggest that vJn & 71/71 electron interactions do not contribute to 
retention. However, we are currently investigating the ability of LSER theory to describe n 
electron complexation in the normal-phase mode. 
3.3.3 Changes in separation mechanism described by LSER 
The mechanism for retention in the reversed-phase mode and the normal-phase mode 
are based on different interactions between solutes and the stationary phase. In the reversed-
phase mode, retention is predominantly influenced by hydrophobic interactions, and, in the 
normal-phase mode, hydrogen bonding and dipolar interactions have the greatest influence 
on retention. These differences in mechanism are readily apparent when considering the 
LSER system constants for a given macrocyclic glycopeptide CSP in both the reversed-phase 
mode and the normal-phase mode (Figure 8). Clearly, the LSER theory is very successful at 
describing these differences in retention mechanism between these two modes of operation. 
Now that these CSPs have been effectively characterized, the next step is to categorize, 
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quantify, and evaluate which combination of interactions is responsible for chiral recognition 
of specific chiral molecules. Furthermore, it may be possible to definitively identify and 
measure the interaction differences between a CSP and two enantiomers. These will be the 
foci of following papers. 
3.4 Conclusions 
The LSER theory is very successful in its ability to describe retention on the 
macrocyclic glycopeptide CSPs, and the differences between conventional stationary phases 
and these macrocyclic glycopeptide CSPs are readily apparent. The sign and magnitude of 
the system constants are in tune with our chemical intuition. The data indicate that, in the 
reversed-phase mode, the solvents sorbed to the macrocyclic glycopeptide stationary phase 
are not as enriched in the organic modifier component as they are in a CI8 stationary phase. 
This has a profound effect on the dipolarity, hydrogen bond basicity, and hydrogen bond 
acidity of these stationary phases. The most noticeable differences are in the dipolarity and 
hydrogen bond acidity of the macrocyclic glycopeptide CSPs, which, when mobile phase 
conditions change, have responses opposite to that of CI 8 stationary phases. In the reversed-
phase mode, retention is governed by dispersive, hydrophobic partitioning, whereas in the 
normal-phase mode, retention is based on competition for hydrogen bonding and dipolar sites 
on the surface of the stationary phase. These differences in mechanism are easily 
differentiated by the LSER system constants. These parameters will be useful in the study of 
chiral interaction mechanisms and the enantioselectivity of CSPs. 
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Figure 1. Structures of the four commercially available macrocyclic glycopeptide chiral 
selectors a) Teicoplanin b) Teicoplanin Aglycon c) Vancomycin and d) Ristocetin A. 
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Figure 2. System constants of Chirobiotic T in the reversed-phase mode at varying 
acetonitrile amounts. 
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Figure 3. System constants of Chirobiotic T in the reversed-phase mode at varying methanol 
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Figure 4. System constants of CIS stationary phase in the reversed-phase mode at varying 
acetonitrile amounts. 
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Figure 5. Comparison of four commercially available macrocyclic glycopeptide CSPs at 
condition log Kw. a) Data extrapolated from acetonitrile retention data, b) Data 
extrapolated from methanol retention data. 
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Figure 7. System constants of Chirobiotic T in the normal-phase mode at varying ethanol 
amounts. 
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Table I. Probe solutes and their solute descriptors used in the reversed-phase mode. Solute 
descriptors E, S, A, B, and V are defined in the Introduction. 
Solute E S A B V 
1,3,5-trihydroxybenzene 1.355 1.12 1.40 0.82 0.8925 
resorscinol 0.980 1.00 1.10 0.58 0.8338 
1-nitrobutane 0.227 0.95 0.00 0.29 0.8464 
benzaldehyde 0.820 1.00 0.00 0.39 0.8730 
3-cyanophenol 0.930 1.55 0.77 0.28 0.9300 
benzonitrile 0.742 1.11 0.00 0.33 0.8711 
acetophenone 0.818 1.01 0.00 0.48 1.0139 
phenol 0.805 0.89 0.60 0.31 0.7751 
2-nitrophenol 1.015 1.05 0.05 0.37 0.9490 
1-nitropentane 0.212 0.95 0.00 0.29 0.9873 
o-cresol 0.840 0.86 0.52 0.30 0.9160 
m-cresol 0.822 0.88 0.57 0.34 0.9160 
p-cresol 0.820 0.87 0.57 0.31 0.9160 
methyl-4-hydroxybenzoate 0.900 1.37 0.69 0.45 1.1313 
nitrobenzene 0.871 1.11 0.00 0.28 0.8906 
ethyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.2722 
1-nitrohexane 0.203 0.95 0.00 0.29 1.1282 
benzene 0.610 0.52 0.00 0.14 0.7164 
4-nitrotoluene 0.870 1.11 0.00 0.28 1.0315 
m-trifluoromethylphenol 0.425 0.87 0.72 0.09 0.9691 
n-propyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.4131 
4-chlorophenol 0.915 1.08 0.67 0.20 0.8970 
toluene 0.601 0.52 0.00 0.14 0.8573 
o-xylene 0.663 0.56 0.00 0.16 0.9982 
m-xylene 0.623 0.52 0.00 0.16 0.9982 
p-xylene 0.613 0.52 0.00 0.16 0.9982 
3-chlorophenol 0.909 1.06 0.69 0.15 0.8970 
valerophenone 0.800 0.95 0.00 0.50 1.4370 
n-butyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.5540 
1-naphthol 1.520 1.05 0.61 0.37 1.1441 
ethyl benzene 0.613 0.51 0.00 0.15 0.9980 
3,4-dichlorophenol 1.020 1.14 0.85 0.03 1.0199 
naphthalene 1.340 0.92 0.00 0.20 1.0854 
hexanophenone 0.720 0.95 0.00 0.50 1.5780 
heptanophenone 0.720 0.95 0.00 0.50 1.7180 
n-propylbenzene 0.604 0.50 0.00 0.15 1.1391 
dibenzothiophene 1.959 1.31 0.00 0.20 1.3791 
n-buytlbenzene 0.600 0.51 0.00 0.15 1.2800 
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Table II. Probe solutes and their solute descriptors used in the normal-phase mode. Solute 
descriptors E, S, A, B, and V are defined in the Introduction. 
Solute E S A B V 
pyrene 2.808 1.71 0.00 0.28 1.5846 
anthracene 2.290 1.34 0.00 0.26 1.4544 
phenanthrene 2.055 1.29 0.00 0.26 1.4544 
dibenzothiophene 1.959 1.31 0.00 0.20 1.3791 
n-buytlbenzene 0.600 0.51 0.00 0.15 1.2800 
ethylbenzene 0.613 0.51 0.00 0.15 0.9980 
o-xylene 0.663 0.56 0.00 0.16 0.9982 
m-xylene 0.623 0.52 0.00 0.16 0.9982 
p-xylene 0.613 0.52 0.00 0.16 0.9982 
toluene 0.601 0.52 0.00 0.14 0.8573 
biphenyl 1.360 0.99 0.00 0.22 1.3242 
naphthalene 1.340 0.92 0.00 0.20 1.0854 
heptanophenone 0.720 0.95 0.00 0.50 1.7180 
hexanophenone 0.720 0.95 0.00 0.50 1.5780 
4-nitrotoluene 0.870 1.11 0.00 0.28 1.0315 
nitrobenzene 0.871 1.11 0.00 0.28 0.8906 
4-iodophenol 1.380 1.22 0.68 0.20 1.0333 
4-bromophenol 1.080 1.17 0.67 0.20 0.9501 
4-chlorophenol 0.915 1.08 0.67 0.20 0.8970 
benzonitrile 0.742 1.11 0.00 0.33 0.8711 
1-naphthol 1.520 1.05 0.61 0.37 1.1441 
o-cresol 0.840 0.86 0.52 0.30 0.9160 
m-cresol 0.822 0.88 0.57 0.34 0.9160 
p-cresol 0.820 0.87 0.57 0.31 0.9160 
n-butyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.5540 
n-propyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.4131 
ethyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.2722 
methyl-4-hydroxybenzoate 0.900 1.37 0.69 0.45 1.1313 
phenol 0.805 0.89 0.60 0.31 0.7751 
nitroethane 0.270 0.95 0.02 0.33 0.5640 
nitromethane 0.313 • 0.95 0.06 0.31 0.4240 
3-cyanophenol 0.930 1.55 0.77 0.28 0.9300 
4-nitrophenol 1.070 1.72 0.82 0.26 0.9490 
aniline 0.955 0.96 0.26 0.53 0.8162 
acetanilide 0.870 1.40 0.50 0.67 1.1133 
pyridine 0.794 0.87 0.00 0.62 0.6753 
resorscinol 0.980 1.00 1.10 0.58 0.8338 
hydroquinone 1.063 1.27 1.06 0.57 0.8338 
benazamide 0.990 1.50 0.49 0.67 0.9728 
dimethylformamide 0.363 1.33 0.00 0.78 0.7877 
dimethylacetamide 0.367 1.31 0.00 0.74 0.6468 
phenylurea 1.100 1.33 0.79 0.79 1.0726 
benzenesulfonamide 1.130 1.55 0.55 0.80 1.0971 
paracetamol 1.060 1.78 1.09 0.81 1.1720 
1,3,5-trihydroxybenzene 1.355 1.12 1.40 0.82 0.8925 
lidocaine 1.010 1.49 0.11 1.27 2.0589 
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succinimide 0.528 1.84 0.52 0.65 0.6948 
theophylline 1.500 1.60 0.54 1.34 1.2223 
caffeine 1.500 1.60 0.00 1.33 1.3632 
thymine 0.800 1.00 0.44 1.83 0.8925 
uracil 0.810 1.00 0.44 1.00 0.7516 
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Table III. Correlation coefficients (r) between the molecular descriptors for the reversed 
phase probe solutes. Solute descriptors E, S, A, B, and V are defined in the Introduction. 
E S A B V 
E 1.00 
S 0.46 1.00 
A 0.07 0.31 1.00 
B 0.08 0.47 0.25 1.00 
V 0.46 0.28 -0.21 0.11 1.00 
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Table IV. Correlation coefficients (r) between the molecular descriptors for the normal-
phase probe solutes. Solute descriptors E, S, A, B, and V are defined in the Introduction. 
E S A B V 
E 1.00 
S 0.46 1.00 
A -0.12 0.29 1.00 
B -0.11 0.36 0.24 1.00 
V 0.59 0.31 -0.22 0.03 1.00 
Table V. System constants in the reversed-phase mode at log kw for macrocyclic glycopeptide CSPs and Cl8 stationary phase, 
is the coefficient of correlation, SE is the standard error of regression, F is the Fisher statistic, n is the number of solutes in 
regression. 
SPa MPb e s a b V Intercept r2 SE F n 
C18 kw MeOH 0.285 -0.787 -0.294 -3.186 4.65 -0.528 0.99 0.104 849 54 
(0.073) (0.072) (0.062) (0.145) (0.107) (0.089) 
TAG kw MeOH 0.533 0.356 -0.535 -1.148 1.958 -1.190 0.99 0.058 535 36 
(0.042) (0.047) (0.034) (0.076) (0.048) (0.057) 
T kw MeOH 0.243 0.299 -0.701 -0.463 1.490 -1.123 0.99 0.047 755 35 
(0.026) (0.038) (0.028) (0.066) (0.039) (0.041) 
V kw MeOH 0.369 0.279 -0.564 -0.458 1.223 -1.193 0.98 0.052 437 35 
(0.029) (0.042) (0.031) (0.073) (0.043) (0.046) 
R kw MeOH 0.783 0.646 -0.898 -0.984 1.317 -1.531 0.98 0.065 257 31 
(0.064) (0.058) (0.053) (0.094) (0.056) (0.069) 
C18 kw ACN 0.120 -0.496 -0.744 -3.813 3.933 -0.001 0.99 0.114 1220 65 
(0.054) (0.076) (0.063) (0.145) (0.071) (0.076) 
TAG kw ACN 0.584 0.214 -0.419 -1.350 2.077 -1.234 0.99 0.062 475 36 
(0.045) (0.050) (0.036) (0.081) (0.051) (0.061) 
T kw ACN 0.381 0.234 -0.534 -0.661 1.443 -1.253 0.99 0.044 745 36 
(0.019) (0.027) (0.020) (0.048) (0.028) (0.030) 
V kw ACN 0.518 0.383 -0.520 -1.339 1.528 -1.607 0.99 0.029 875 32 
(0.020) (0.026) (0.018) (0.053) (0.023) (0.026) 
R kw ACN 0.799 0.716 -0.887 -1.454 1.500 -1.798 0.99 0.045 443 30 
(0.023) (0.029) (0.022) (0.055) (0.023) (0.028) 
i) SP- stationary phase, b) MP ' - mobile phase 
Table VI. LSER system constants for macrocyclic glycopeptide CSPs and Cl8 stationary phase in the reverse phase mode. 
Entries in bold are indistinguishable from zero. 
SP" MPb e s a b v Intercept r2 SE F n 
TAG 20% ACN 0.374 -0.001 -0.315 -1.202 1.349 -0.779 0.99 0.048 481 35 
(0.029) (0.039) (0.027) (0.061) (0.040) (0.043) 
TAG 15% ACN 0.443 0.037 -0.334 -1.277 1.550 -0.915 0.98 0.051 419 36 
(0.037) (0.041) (0.030) (0.066) (0.042) (0.050) 
TAG 10% ACN 0.488 0.090 -0.349 -1.315 1.730 -1.026 0.98 0.054 451 36 
(0.039) (0.043) (0.031) (0.070) (0.044) (0.052) 
TAG 5% ACN 0.530 0.161 -0.394 -1.312 1.913 -1.133 0.99 0.056 499 36 
(0.040) (0.045) (0.033) (0.073) (0.046) (0.055) 
TAG 25% MeOH 0.478 0.267 -0.493 -1.211 1.496 -1.109 0.99 0.048 506 36 
(0.035) (0.039) (0.028) (0.063) (0.040) (0.047) 
TAG 20% MeOH 0.497 0.265 -0.484 -1.237 1.615 -1.136 0.99 0.050 515 36 
(0.036) (0.040) (0.029) (0.065) (0.041) (0.049) 
TAG 15% MeOH 0.527 0.276 -0.492 -1.189 1.695 -1.160 0.99 0.051 547 36 
(0.036) (0.041) (0.029) (0.066) (0.042) (0.049) 
TAG 10% MeOH 0.518 0.324 -0.506 -1.164 1.775 -1.192 0.99 0.056 487 36 
(0.040) (0.045) (0.032) (0.073) (0.046) (0.054) 
TAG 5% MeOH 0.514 0.346 -0.533 -1.186 1.837 -1.125 0.98 0.056 391 34 
(0.040) (0.045) (0.032) (0.074) (0.055) (0.06) 
T 20% ACN 0.228 0.108 -0.368 -0.794 0.909 -0.953 0.99 0.034 558 36 
(0.025) (0.035) (0.025) (0.062) (0.036) (0.039) 
T 15% ACN 0.269 0.129 -0.388 -0.792 1.031 -1.017 0.99 0.033 704 36 
(0.021) (0.031) (0.022) (0.054) (0.032) (0.034) 
T 10% ACN 0.320 0.148 -0.430 -0.757 1.153 -1.075 0.99 0.039 616 36 
(0.022) (0.031) (0.023) (0.055) (0.032) (0.034) 
T 5% ACN 0.335 0.207 -0.503 -0.683 1.322 -1.184 0.99 0.038 829 35 
(0.018) (0.026) (0.019) (0.047) (0.027) (0.029) 
T 25% MeOH 0.260 0.315 -0.523 -0.692 1.000 -1.132 0.99 0.039 577 35 
(0.022) (0.032) (0.023) (0.055) (0.032) (0.034) 
T 20% MeOH 
T 15% MeOH 
T 10% MeOH 
T 5% MeOH 
V 20% ACN 
V 15% ACN 
V 10% ACN 
V 5% ACN 
V 25% MeOH 
V 20% MeOH 
V 15% MeOH 
V 10% MeOH 
V 5% MeOH 
R 20% ACN 
R 15% ACN 
0.272 
(0.022) 
0.282 
(0.021) 
0.280 
(0.022) 
0.223 
(0.024) 
0.406 
(0.025) 
0.454 
(0.023) 
0.472 
(0.021) 
0.486 
(0.022) 
0.364 
(0.024) 
0.369 
(0.021) 
0.377 
(0.025) 
0.360 
(0.022) 
0.294 
(0.028) 
0.539 
(0.042) 
0.599 
(0.037) 
0.323 
(0.031) 
0.313 
(0.030) 
0.299 
(0.031) 
0.307 
(0.034) 
0.176 
(0.032) 
0.228 
(0.030) 
0.269 
(0.028) 
0.335 
(0.028) 
0.267 
(0.035) 
0.268 
(0.031) 
0.287 
(0.036) 
0.271 
(0.032) 
0.293 
(0.041) 
0.379 
(0.053) 
0.450 
(0.047) 
-0.541 
(0.023) 
-0.568 
(0.022) 
-0.605 
(0.023) 
-0.685 
(0.025) 
-0.371 
(0.023) 
-0.388 
(0.021) 
-0.420 
(0.019) 
-0.495 
(0.020) 
-0.431 
(0.026) 
-0.443 
(0.023) 
-0.456 
(0.026) 
-0.507 
(0.024) 
-0.581 
(0.030) 
-0.587 
(0.041) 
-0.641 
(0.036) 
-0.684 
(0.054) 
-0.638 
(0.052) 
-0.588 
(0.054) 
-0.484 
(0.060) 
-1.140 
(0.065) 
-1.246 
(0.062) 
-1.278 
(0.056) 
-1.271 
(0.058) 
-0.803 
(0.062) 
-0.743 
(0.053) 
-0.680 
(0.063) 
-0.617 
(0.056) 
-0.579 
(0.072) 
-1.164 
(0.102) 
-1.296 
(0.090) 
1.102 
(0.032) 
1.207 
(0.031) 
1.301 
(0.032) 
1.385 
(0.035) 
0.961 
(0.028) 
1.138 
(0.026) 
1.256 
(0.024) 
1.381 
(0.025) 
0.960 
(0.036) 
1.026 
(0.032) 
1.102 
(0.037) 
1.155 
(0.033) 
1.177 
(0.042) 
0.945 
(0.042) 
1.124 
(0.037) 
-1.154 0.99 
(0.034) 
-1.177 0.99 
(0.032) 
-1.177 0.99 
(0.034) 
-1.084 0.99 
(0.037) 
-1.370 0.99 
(0.032) 
-1.466 0.99 
(0.031) 
-1.499 0.99 
(0.028) 
-1.541 0.99 
(0.029) 
-1.338 0.98 
(0.039) 
-1.330 0.99 
(0.033) 
-1.316 0.99 
(0.039) 
-1.277 0.99 
(0.035) 
-1.179 0.98 
(0.045) 
-1.594 0.99 
(0.052) 
-1.665 0.99 
(0.046) 
0.039 674 35 
0.037 847 35 
0.039 871 35 
0.042 834 35 
0.024 497 32 
0.026 571 32 
0.025 761 31 
0.028 799 32 
0.044 416 35 
0.038 598 35 
0.044 481 35 
0.040 662 35 
0.051 437 35 
0.024 550 30 
0.027 608 30 
R 10% ACN 0.664 0.523 -0.708 -1.349 1.252 
(0.030) (0.038) (0.029) (0.073) (0.030) 
R 5% ACN 0.737 0.643 -0.827 -1.363 1.347 
(0.025) (0.032) (0.025) (0.062) (0.025) 
R 25% MeOH 0.689 0.660 -0.816 -1.101 0.930 
(0.035) (0.032) (0.029) (0.052) (0.031) 
R 20% MeOH 0.713 0.661 -0.824 -1.099 1.021 
(0.037) (0.034) (0.031) (0.055) (0.033) 
R 15% MeOH 0.743 0.632 -0.815 -1.050 1.137 
(0.047) (0.043) (0.039) (0.070) (0.042) 
R 10% MeOH 0.764 0.645 -0.850 -1.023 1.182 
(0.049) (0.044) (0.041) (0.072) (0.043) 
R 5% MeOH 0.749 0.658 -0.898 -1.017 1.216 
(0.056) (0.051) (0.047) (0.083) (0.049) 
C18 40% ACN 0 -0.307 -0.575 -2.058 1.960 
(0.028) (0.029) (0.057) (0.029) 
C18 35% ACN 0 -0.349 -0.620 -2.425 2.363 
(0.029) (0.030) (0.058) (0.030) 
C18 30% ACN 0 -0.331 -0.613 -2.558 2.521 
(0.036) (0.037) (0.072) (0.040) 
a) SP - stationary phase, b) MF ' - mobile phase 
-1.716 0.99 
(0.037) 
-1.736 0.99 
(0.031) 
-1.631 0.99 
(0.038) 
-1.634 0.99 
(0.040) 
-1.651 0.98 
(0.051) 
-1.610 0.98 
(0.053) 
-1.514 0.98 
(0.061) 
-0.035 0.99 
(0.035) 
-0.316 0.99 
(0.035) 
-0.064 0.99 
(0.045) 
0.032 564 29 
0.039 465 30 
0.035 531 31 
0.038 518 31 
0.048 362 31 
0.049 365 31 
0.057 300 31 
0.052 1988 65 
0.052 2468 64 
0.065 1641 63 
Table VII. System constants in the normal phase mode at Log khep for macrocyclic glycopeptide CSPs. 
SPa MPb e s a b V Intercept r2 SE F n 
TAG k hep 0 0.871 0.909 2.536 -1.172 -0.495 0.99 0.109 704 42 
(0.066) (0.053) (0.103) (0.063) (0.080) 
T k hep 0 0.756 1.010 2.198 -1.115 -0.537 0.98 0.130 530 . 44 
(0.074) (0.061) (0.097) (0.071) (0.091) 
V k hep 0 1.095 1.080 1.829 -1.077 -0.671 0.99 0.100 775 37 
(0.090) (0.054) (0.098) (0.061) (0.082) 
R k hep 0 0.803 0.980 2.168 -1.192 -0.428 0.98 0.122 559 45 
(0.072) (0.059) (0.087) (0.062) (0.080) 
a) SP - stationary phase, b) MP - mobile phase 
Table VIII. LSER system constants for macrocyclic glycopeptide CSPs in the normal phase mode. 
SPa MPb e s a b V Intercept r2 SE F n 
TAG 25% EtOH Hept 0 0.662 0.056 1.681 -0.917 -0.473 0.98 0.098 449 46 
(0.053) (0.041) (0.070) (0.053) (0.067) 
TAG 20% EtOH Hept 0 0.691 0.149 1.759 -0.955 -0.460 0.98 0.102 477 46 
(0.055) (0.042) (0.073) (0.055) (0.070) 
TAG 15% EtOH Hept 0 0.717 0.279 1.875 -1.001 -0.420 0.98 0.104 543 46 
(0.057) (0.043) (0.074) (0.057) (0.072) 
TAG 10% EtOH Hept 0 0.774 0.473 2.004 -1.014 -0.487 0.98 0.108 568 45 
(0.059) (0.047) (0.096) (0.060) (0.077) 
TAG 5% EtOH Hept 0 0.839 0.798 2.500 -1.149 -0.504 0.98 0.110 622 42 
(0.067) (0.053) (0.105) (0.064) (0.082) 
T 25% EtOH Hept 0 0.560 0.144 1.455 -0.826 -0.570 0.97 0.090 432 46 
(0.049) (0.037) (0.064) (0.049) (0.061) 
T 20% EtOH Hept 0 0.573 0.233 1.520 -0.848 -0.529 0.98 0.093 459 46 
(0.050) (0.038) (0.066) (0.050) (0.063) 
T 15% EtOH Hept 0 0.615 0.352 1.629 -0.896 -0.529 0.98 0.104 442 46 
(0.057) (0.043) (0.074) (0.057) (0.072) 
T 10% EtOH Hept 0 0.664 0.542 1.796 -0.979 -0.510 0.98 0.112 506 46 
(0.061) (0.047) (0.080) (0.061) (0.077) 
T 5% EtOH Hept 0 0.743 0.911 2.107 -1.082 -0.566 0.98 0.125 515 44 
(0.071) (0.059) (0.094) (0.068) (0.088) 
V 25% EtOH Hept 0 0.699 0.201 1.307 -0.793 -0.587 0.99 0.060 888 39 
(0.044) (0.027) (0.052) (0.035) (0.048) 
V 20% EtOH Hept 0 0.753 0.296 1.369 -0.824 -0.601 0.99 0.069 773 39 
(0.051) (0.032) (0.061) (0.041) (0.055) 
V 15% EtOH Hept 0 0.805 0.420 1.446 -0.855 -0.600 0.99 0.077 745 39 
(0.057) (0.035) (0.068) (0.045) (0.061) 
V 10% EtOH Hept 0 0.871 0.607 1.578 -0.914 -0.611 0.99 0.085 789 39 
(0.063) (0.039) (0.074) (0.050) (0.068) 
V 5% EtOH Hept 0 1.006 0.966 1.930 -1.006 -0.721 0.99 0.087 859 36 
(0.079) (0.048) (0.103) (0.054) (0.074) 
R 25% EtOH Hept 0 0.664 0.086 1.372 -0.880 
(0.064) (0.047) (0.072) (0.054) 
R 20% EtOH Hept 0 0.656 0.204 1.460 -0.938 
(0.059) (0.048) (0.069) (0.055) 
R 15% EtOH Hept 0 0.680 0.331 1.530 -0.971 
(0.064) (0.051) (0.074) (0.059) 
R 10% EtOH Hept 0 0.711 0.496 1.824 -1.043 
(0.059) (0.048) (0.077) (0.055) 
R 5% EtOH Hept 0 0.760 0.869 2.233 -1.079 
(0.066) (0.053) (0.099) (0.063) 
a) SP - stationary phase, b) MP - mobile phase 
-0.513 
(0.073) 
-0.453 
(0.071) 
-0.415 
(0.077) 
-0.439 
(0.072) 
-0.557 
(0.081) 
0.97 0.103 337 45 
0.97 0.112 361 49 
0.97 0.120 367 49 
0.98 0.112 519 48 
0.98 0.109 577 43 
00 
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CHAPTER 4 
Factors that Contribute to Enantioselectivity in Macrocyclic Glycopeptide 
Chiral Stationary Phases in the Reversed Phase Mode 
A paper submitted to Journal of Chromatography A 
Clifford R. Mitchell, Daniel W. Armstrong 
Abstract 
The linear solvation energy relationship (LSER) model was utilized to examine the 
mechanism of enantioseparation on the Chirobiotic T chiral stationary phase. The solute 
descriptors of 12 racemates, including 5 neutral compounds, 5 amino acids, and 2 N-blocked 
amino acids, were determined in the reversed-phase mode with ethanol/buffer mobile phases. 
LSER system constants and solute descriptors were determined for the systems and solutes 
studied, and the intermolecular interactions that contribute to retention and enantioselectivity 
were obtained. It was found that ion-dipole interactions and steric repulsion interactions had 
the greatest impact on enantioselectivity. Hydrogen bonding, donation and acceptance, had a 
moderate effect on enantioselectivity, and dipole-dipole interactions have the least effect on 
enantioselectivity. One chiral sulfoxide was studied with both ethanol/buffer and 
methanol/water mobile phases, and the LSER model was able to successfully describe the 
differences in the mechanism of enantioseparation when using these two mobile phases. The 
retention data yielded excellent statistical fits for the solute descriptors of each enantiomer. 
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Generally, the neutral compounds experienced a minimum of three different types of 
intermolecular interactions that contribute to enantioselectivity and the amino acids 
experienced a minimum of four different types of intermolecular interactions that contribute 
to enantioselectivity. Theoretically, this approach to the evaluation of enantioselectivity and 
retention can be used for any chiral stationary phase in any chromatographic mode. 
4.1 Introduction 
Despite the advances made in enantiomeric separations over the last 25 years, there 
are only a few widely accepted and utilized approaches for determining the mechanism of 
chiral recognition. The most prevalent method for studying chiral recognition involves the 
use of structure-activity relationships [1-6] in which a large group of chiral molecules are 
analyzed on a given chiral stationary phase (CSP), and changes in enantioselectivity are 
correlated with structural changes. Although the conclusions drawn from these studies are 
well founded, they are usually only qualitative, pertain only to the class of molecules 
analyzed in the study and generally do not definitively reveal all of the interactions occurring 
between the solute and the chiral selector nor their relative importance (magnitude). 
Other methods for studying enantiomeric separations are thermodynamic/van't Hoff 
studies, X-ray crystallography, NMR spectroscopy utilizing Nuclear Overhauser Effects 
(NOEs), computational analysis, and statistical methods. Thermodynamic or van't Hoff 
studies are simple to conduct, give quantitative results, and, when analyzing a large number 
of similar compounds, can give useful information about the role of structural features in 
generating enantioselectivity [7-13]. However the results obtained are in terms of changes of 
free energy, enthalpy, and entropy, and do not explicitly identify the interactions that are 
81 
occurring between the chiral selector and the solute. X-ray crystallography does give a 
precise picture of the interaction of an enantiomer with a chiral selector [14-18]; however, 
the type of intermolecular interactions must be inferred by the proximity of groups on the 
chiral selector and analyte. Also, it is necessary to grow a crystal of the diastereomeric 
complex, which is not possible in many cases. Furthermore, the x-ray structure of the 
complex only describes interaction in the crystal state and does not necessarily describe what 
is occurring in a solvated system or capture the differences between the reversed-phase mode 
and normal-phase mode of HPLC operation. Likewise, computational studies can also 
produce a detailed picture of the interaction of an enantiomer and chiral selector. However, 
many studies omit the presence of buffers, counter ions, solvent environments, are carried out 
with simplified structures for the chiral selector and guest enantiomer, and encounter 
difficulty in accounting for tethering effects when anchoring the chiral selector to a support 
[19-21]. Consequently, competition for interactions with the chiral selector by mobile phase 
solvent molecules and changes in the conformation of the chiral selector due to the 
polarity/composition of the mobile phase will be neglected in these computational models 
[19-21], NMR spectroscopy has been used to study chiral recognition in the solution state 
via intermolecular NOEs as a single method of analysis [22-24] or in conjunction with some 
of the other techniques mentioned above [25-28]. Intermolecular NOEs are very useful in 
describing the orientation of a chiral selector to a single enantiomer. Most of the examples in 
the literature focus on separations that have large enantioselectivities (a-values greater than 
10). 
While all of these methods do provide useful information about chiral recognition, the 
results are often not specific in regard to the exact intermolecular interactions involved and 
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their relative importance, and do not account for solvation or changes in the mode of 
operation. From a chiral selector design viewpoint, it is desirable to know which 
intermolecular interactions contribute to retention and enantioselectivity. 
The techniques that have been most successful in describing intermolecular 
interactions between a chiral selector and chiral solute utilize molecular descriptors of the 
solutes studied and derived descriptors for the chiral selector. Quantitative structure-activity 
relationships (QSARs) have been used with varying success, often identifying one or two 
factors that influence retention or enantioselectivity [29-39]. Linear solvation energy 
relationships (LSERs) have been used to characterize retention on CSPs [40] and describe 
enantioselectivity [41-43], Other studies have utilized regression or correlation to explore 
intermolecular forces between a chiral selector and enantiomers. For example, Roussel et al. 
studied enantiomeric separations of N-arylthiazoline-2-(thi)one atropisomers on derivatized 
cellulosic and amylosic CSPs by factorial design and lipophillic correlation [44, 45]. We 
desire to study chiral separations via a LSER that is comprehensive in its ability to describe 
both retention and selectivity with little to no redundancy in the molecular descriptors or 
ambiguity in the intermolecular interactions they describe. 
4.2 Theoretical 
The LSER theory developed by Abraham describes partitioning in biphasic systems 
[46]. The LSER equation 
Log K = c + eE + sS + aA + bB + vV (1) 
contains five terms. The term for interactions through polarizable n and n electrons is (eE), 
the term for dipole-dipole interactions is (sS), the term for a solute donating a hydrogen atom 
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and the system donating a lone pair of electrons in a hydrogen bond is (aA), the term for a 
solute donating a lone pair of electrons and the system donating a hydrogen atom in a 
hydrogen bond is (M3), and the term for dispersion interactions is (vV). The c term contains 
the chromatographic phase ratio. Each term contains two components; one component 
describes a solutes ability to participate in the specified interaction (the upper case letters 
which are called solute descriptors), and the other component describes the systems ability to 
participate in the specified interaction (the lower case letters which are called system 
constants). 
To apply the LSER model to enantioselectivity, an expression must be derived 
relating chromatographic selectivity to the LSER terms. Selectivity is defined by the 
following relationship 
Taking the logarithm of the selectivity expression and rearranging gives 
Log a = Log ^ - = LogK 2 - LogK, (3 ) 
K\ 
Substituting the LSER equation (1) for each log K and rearranging gives 
Loga = [(e£2 — eEx  ) + (siS'2 — sSx  )+ (aA2  — aA l  )+ {bB2  — bBx  )+ {vV2  — vV ]  ) + (c2  — c, )] (4) 
and can be reduced to the following 
Logcc — \SE2 — eE] )+ (s52 — sS, )+ {CIA2 — aA] )+ {bB2 — bBl )+ {vV2 — vVl )] (5) 
Note that the c terms are constant and identical for a system and therefore are equal. If we 
define, for a solute descriptor, AX as X2-X1, we can simplify the selectivity expression to 
Loga - eAE + sAS + aAA + bAB+ vAV (6) 
The terms, such as s AS, are components of chromatographic selectivity and are a measure of 
the importance of the specified interaction, in this case dipole-dipole interactions, to 
enantioselectivity. With knowledge of the systems constants and the solute descriptors of 
chiral compounds, it is possible to calculate the importance of each interaction accounted for 
by the LSER theory to enantioselectivity. 
To perform this kind of analysis, it is necessary to be able to determine the system 
constants as well as the solute descriptors for each enantiomer. Determination of system 
constants is a fairly routine matter and has been the subject of many publications [47-60], A 
given system (e.g., a stationary phase) is interrogated with probe solutes that have well 
defined solute descriptors. With the log K and solute descriptors of a large number of 
solutes, the system constants can be determined by multiple linear regression. Solute 
descriptors can be determined in a similar fashion (although this is performed less frequently) 
[46, 61-64]; instead of interrogating a system with many well characterized probe solutes, a 
solute (or racemate) can be interrogated with many well characterized systems. The log K of 
a given enantiomer will be determined at a given system composition (mobile phase 
composition, temperature, and chiral selector) that has already been characterized by the 
LSER theory. Multiple linear regression will then be used to determine the solute 
descriptors, and the factors that contribute to retention and enantioselectivity can be 
determined according to equations 1 and 6, respectively. 
Normally, the solute descriptors of each enantiomer should be identical because they 
have identical physical and chemical properties in an isotropic environment. However, they 
do have different properties in the chiral environment of the HPLC CSP; otherwise, they 
could not be separated. The solute descriptors determined by our method are likely similar in 
magnitude to the solute descriptors determined in an isotropic environment but should not be 
taken as the actual "universal" solute descriptors. 
While a range of system conditions are used (temperature and mobile phase 
composition), it is necessary to maintain consistency in the mechanism of enantioseparation. 
Therefore, only one chiral selector and one mode of operation are used in a given 
determination and the conditions utilized are restricted to a somewhat narrow range. 
We envision that this LSER approach can be used in at least three different ways for 
the study of enantiomeric separations. The first approach would be to identify the exact 
factors that influence enantioselectivity (as well as their relative importance) for compounds 
on a given CSP in one mode of operation. This would allow more exact correlations to be 
drawn between molecular structure and the factors contributing to enantioselectivity. 
Alternatively, the LSER approach could be used to determine the factors that influence 
enantioselectivity for a single compound on multiple stationary phases in the same mode of 
operation. This would reveal the difference in separation mechanism between different 
CSPs. Finally, the LSER approach can be used to pinpoint the factors that influence 
enantioselectivity for a single compound on a single CSP in different modes of operation or 
with different mobile phase compositions. This would reveal the difference in separation 
mechanisms that are active in each particular mode. In this study, we will perform the first 
type of analysis listed above. Also, we will show how changes in the nature of the organic 
modifiers (in a reversed-phase separation) change specific enantioselective interactions. 
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4.3 Experimental 
4.3.1 Materials 
The Chirobiotic T stationary phase used was obtained from Advanced Separation 
Technologies (Whippany, NJ) and consisted of the teicoplanin chiral selector bonded to 5 jj.m 
spherical silica gel. The dimensions of the columns are 50 x 4.6 mm. 
Methanol, triethylamine, sodium acetate, and phosphoric acid were HPLC grade from 
Fisher (Fairlawn, NJ). Ethanol was punctilious grade from Aaper alcohol (Shelbyville, KY). 
HPLC water was obtained by treating in-house reverse osmosis water with an ion-exchange 
resin. All LSER probe solutes and most chiral solutes were obtained from Aldrich (St. Louis, 
MO) in high purity grade (99% or greater). The substituted dihydrofurocoumarin was from a 
previous synthetic preparation [65, 66], as were the chiral sulfoxides [67, 68]. 
4.3.2 Instrumental 
The HPLC system used consisted of a quaternary pump, an auto sampler, a UV VWD 
detector (1050, Hewlett Packard, Palo Alto, CA, USA), an integrator (3395, Hewlett 
Packard), and a Jetstream + column thermostat (Advanced Separation Technologies) capable 
of regulating column temperature from 0 to 80 °C. Mobile phases were degassed by a 
sparging with helium for ~5 minutes. UV detection was carried out at 210 nm. 
The buffered aqueous component of the mobile phase was composed of 0.1% (v/v) 
triethylamine and 10 mM sodium acetate (TE A A buffer) in water and brought to pH 4.1 with 
concentrated phosphoric acid. Mobile phase solutions were made by combining the 
appropriate amounts of organic solvent and aqueous buffer to achieve the desired ratio. 
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4.3.3 Calculation 
Retention factors (k) were calculated using the equation k = (tr - t^)/t^. 
Enantioselectivity factors (a) were calculated using the formula a = k^/k^. Multiple linear 
regression analysis and statistical calculations were performed by using the program 
Analyse-it, a statistics package for Microsoft Excel. 
4.4 Results and Discussion 
Twenty-two reversed-phase conditions, each having a unique combination of mobile 
phase composition and temperature, were characterized by the LSER theory, and system 
constants were obtained by multiple linear regression (see Supplemental Table I and II for 
the LSER probe solutes and system constants). Additionally, the retention factors for both 
enantiomers of the 12 racemates selected for this study (see Figure 1 for structures) were 
determined at each condition. The reversed-phase mobile phases were ethanol/buffer 
solutions (10 mM TEAA, pH 4.1). Solute descriptors were determined for each enantiomer 
by linear regression, and the components of retention and enantioselectivity were determined 
according to equations 1 and 6, respectively. 
The results for the analysis of 5-methyl-5-phenyl-hydantoin are shown in Figure 2. 
The solute descriptors (Figure 2a) for both enantiomers were determined by linear regression 
analysis. The coefficient of correlation (r2) is quite good for both regressions (one for each 
enantiomer), 0.99 or better, and the standard deviations of the fitting coefficients (solute 
descriptors) are small, compared with the magnitude of the coefficients (Table I). The 
differences in these solute descriptors are due to the enantioselective interactions experienced 
with the chiral selector, teicoplanin. The factors that contribute to retention (log K) are 
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shown in Figure 2b (Table II). These values are the product of the solute descriptors and the 
system constants, from equation 1 (the system constants used were for a 25/75 ethanol/buffer 
mobile phase at 25°C). The factors that contribute to enantioselectivity are shown in Figure 
2c (Table III). These values are the terms of equation 6, which are the differences in the 
factors that contribute to retention. In this type of analysis, it is enlightening to consider both 
the factors that contribute to selectivity and retention. This is a notable difference in our 
approach versus the method of Blackwell et al. [42, 43]. 
Some of the factors that control enantioselectivity (i.e., the different interactions for 
each enantiomer) are very straightforward to see and understand. Other factors require 
interpretation. The dipolar (sAS) and hydrogen bonding terms (aAA and bAB) are straight­
forward as to what is occurring between the chiral solute and the stationary phase. The 
dipolar term (sAS) describes dipole-dipole interactions occurring between the enantiomers 
and the chiral selector. In the case of 5-methyl-5-phenyl-hydantoin, the sAS term is -0.048, 
which suggests that dipole-dipole interaction do not significantly contribute to 
enantioselectivity. Note that while the sAS is essentially zero, dipole-dipole interactions do 
contribute to retention (Fig. 2b). The sSi and sS? terms are positive, indicating that dipole-
dipole interactions contribute to the enantiomers association with the stationary phase (Fig. 
2b). The aAA hydrogen bonding term indicates a hydrogen bond being donated by the 
enantiomers and accepted by the chiral selector, and the bAB hydrogen bonding term 
indicates a hydrogen bond being donated by the chiral selector and accepted by the 
enantiomers. In this case, the values of the aAA and bAB terms are 0.33 and 0.23, 
respectively. Because these values are positive, the second eluting enantiomer experiences 
more enantioselective hydrogen bonding interactions with the chiral selector, compared with 
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the first eluting enantiomer. Additionally, only the second eluting enantiomer experiences a 
significant amount of hydrogen bonding with the stationary phase that contributes with 
retention (Fig. 2b). The aA, and bB, factors are zero and -0.10, while the aAi and bB? 
factors are 0.33 and 0.14, respectively 
The dispersion term (vAV) requires more interpretation. A positive value for vAV 
would suggest dispersion forces and hydrophobic interactions contributing to 
enantioselectivity. However, for 5-methyl-5-phenyl-hydantoin (and all other compounds in 
this study) the vAV term has a value of -0.62; the first eluting enantiomer experiences more 
dispersion forces than the second enantiomer. This is likely an indication of steric repulsions 
contributing to enantioselectivity. The first eluting enantiomer experiences a steric repulsion 
with the chiral selector, which is manifested in the larger vV, term, causing it to elute before 
the second enantiomer, which experiences less steric repulsion and has a smaller vV% term. It 
has been well established for the Chirobiotic T CSP, and other CSPs of this family, that steric 
repulsion interactions are a significant constituent of enantioselectivity [69]. 
The final term that contributes to enantioselectivity is the excess molar refraction 
term, eAE. This term encodes interaction through polarizable n and n electrons. Recently, 
we determined that, in the reversed-phase mode, the excess molar refraction term can encode 
both 7i electron complexation and ion-dipole interactions [70]. Additionally, we have shown 
that the macrocyclic glycopeptide CSPs are rather weak n electron complexation stationary 
phases [71], and it is well established that electrostatics play an important role in retention 
and enantioselectivity in the reversed-phase mode [69]. In light of this, it is likely that the 
interactions that are measured by the eAE term are ion-dipole interactions. For 5-methyl-5-
phenyl-hydantoin the eAE term is 0.50, and is the generated by ion-dipole interactions 
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involving the ionized amine residue on the teicoplanin chiral selector (which has proven to be 
important to enantioselectivity on this CSP [72, 73]). 
In addition to determining which factors contribute to retention and 
enantioselectivity, results are in good agreement with previous studies on the selected CSP 
and the LSER description of retention and enantioselectivity is very consistent with 
experimentally obtained results. The enantioselectivity value for 5-methyl-5-phenyI-
hydantoin is 2.41 when experimentally determined according to equation 2 (when using a 
mobile phase of 25/75 ethanol/buffer mobile phase at 25°C). When calculating the 
enantioselectivity of 5-methyl-5-phenyl-hydantoin with the LSER method (using system 
constants of the identical condition), equation 6 gives an enantioselectivity value of 2.50, a 
difference of a few percent (3.66%). Figure 3 is a plot of observed versus calculated 
selectivity factors for every compound in this study. The coefficient of correlation (r2) is 
0.99, indicating that the LSER's description of enantioselectivity correlates nearly perfectly 
with experimental values. Additionally, the correlation between calculated and observed log 
K is also excellent. A significant difference in these values would indicate that there could 
be inconsistencies in our proposed model or the calculations performed. 
The LSER method was used to analyze the retention and enantioselectivity of several 
other neutral molecules. The compounds ranged from polar (bromacil and 5-methyl-5-
phenyl-hydantoin), intermediate polarity (a-naphthalenyl methyl sulfoxide), to nonpolar (the 
substituted dihydrofurocoumarin and 1,1 -dimethyl-3-phenyl-propyl toluyl sulfoxide). Solute 
descriptors were generated for both enantiomers using linear regression (Table I), and, like 
the results from 5-methyl-5-phenyl-hydantoin discussed above, the fits of the regressions 
were quite good. 
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These neutral compounds have several common features in the factors that contribute 
to their enantioselectivity. First, all these neutral molecules have positive eAE terms and 
negative vAV terms, indicating that ion-dipole interactions and steric repulsions are 
important in chiral recognition on the teicoplanin CSP. A second common feature is the 
near-zero value of the sAS terms for all compounds, which suggests that, on the teicoplanin 
CSP in the reversed-phase mode (with the ethanol/buffer mobile phase), dipole-dipole 
interactions are not a significant component of enantioselectivity. Dipole-dipole interactions 
do contribute to retention (Table II) but in equal amounts for each enantiomer. Most of the 
neutral molecules have no interaction through the a-type of hydrogen bonding. This is a 
consequence of these particular solutes not possessing acidic hydrogen atoms for the a-type 
of hydrogen bonding. Consequently, the "A" solute descriptor for most of the neutral 
analytes is zero, and the aAA term is zero. Finally, additional enantioselective interactions 
are generated by varying amounts of the b-type of hydrogen bonding. 
4.4.1 Comparison of enantioselectivity components from two different mobile phases 
In a separate experiment, a-naphthalenyl methyl sulfoxide was eluted with 
methanol/water mobile phases (as opposed to ethanol/buffer mobile phases). The solute 
descriptors for a-naphthalenyl methyl sulfoxide were determined from these data by linear 
regression analysis (Table I). Note that the solute descriptors generated from a different 
mobile phase system will differ because of changes in the mechanism of enantioseparation. 
The factors that comprise retention and enantioselectivity were determined according to 
equations 1 and 6, respectively, and are listed in Tables II and III. Figure 4 compares the 
factors that contribute to enantioselectivity for a-naphthalenyl methyl sulfoxide in both 
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mobile phases. While none of the factors derived from the ethanol/buffer mobile phase have 
the same magnitude as the factors from the methanol/water mobile phase (except for the aAA 
term, which is zero because sulfoxides are not capable of this type of hydrogen bonding), the 
sign and magnitude of some of the terms are similar. The eAE terms are positive for both 
mobile phases, and vAV terms are negative for both mobile phases. In the methanol/water 
mobile phase, the magnitude of the eAE term is similar to the magnitude of the 
methanol/water vAV term. The same is true of the eAE and vAV terms in the ethanol/buffer 
mobile phases. Additionally, these two terms have the greatest magnitude, and therefore 
impact on enantioselectivity, of any of the terms (in their respective mobile phases). 
There are significant differences in the sAS and bAB terms for the two mobile phases. 
The sAS term is zero for the ethanol/buffer mobile phase and 0.13 for the methanol/water 
mobile phase, and the bAB term is 0.46 for the ethanol/buffer mobile phase and -0.03 for the 
methanol/water mobile phase. It is well established that the nature of the organic modifier 
has a strong impact on enantioselectivity in chiral separations, and these changes can only be 
due to the differences between methanol and ethanol, and the presence of buffer components 
(triethylamine and acetic acid). Despite the similarities in the terms of enantioselectivity, 
both enantioselectivities are predicted fairly accurately by the LSER model, the 
chromatographically observed and LSER predicted values are 1.63 and 1.59 for the ethanol 
buffer system, and 1.39 and 1.30 for the methanol/water system. 
4.4.2 Results from the analysis of amino acids 
The macrocyclic glycopeptide CSPs have excellent selectivity for amino acids and 
are able to baseline separate all 19 chiral protenic amino acids, as well as a wide variety of 
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non-protenic chiral amino acids [69, 74-84], Indeed, nature has selected these compounds to 
discriminate between enantiomers of amino acids. In vivo the macrocyclic glycopeptides 
vancomycin and teicoplanin act as antibiotics by binding to D-alanine-D-alanine residues on 
the cell walls of enemy bacteria [85-87], preventing cell wall growth and eventually causing 
cell death. Given this broad selectivity for amino acids, one would expect the 
enantioseparation mechanism to be fairly consistent, depending only partially on the amino 
acid side chain. 
Several amino acids were examined on the teicoplanin CSP in the reversed-phase 
mode. Solute descriptors were determined by linear regression. The quality of the 
regressions were not as good as those for the neutral compounds studied but still sufficient to 
generate solute descriptors for the enantiomers studied that are statistically different from 
each other. The solute descriptors for the selected amino acids (arginine, methionine, phenyl 
glycine, m-tyrosine, and tryptophan) and two N-blocked amino acids (N-acethyl-m-fluoro-
phenylalanine and N-benzoyl-phenylalanine) are listed in Table IV, with the factors that 
comprise retention and enantioselectivity in Tables V and VI, respectively. In Figure 5, the 
factors that contribute to enantioselectivity for these amino acids are displayed. 
When examining the magnitude and sign of these values, there are many common 
features in the factors that comprise enantioselectivity of each amino acid. Once again, the 
eAE terms are positive and the vAV terms are negative, and the magnitude of these terms are 
the largest for each amino acid. Additionally, the sAS terms are all negative in sign and 
among the smallest in magnitude for each amino acid, with values ranging from -0.06 to -
0.32. Finally, the hydrogen bonding terms aAA and bAB are also significant, being positive 
in value and generally similar in magnitude. These results indicate that ion-dipole 
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interactions (eAE), and steric repulsions (vAV) are the interactions that have the strongest 
impact on enantioselectivity, both types of hydrogen bonding (aAA and bAB) have a weaker 
impact on enantioselectivity, and dipole-dipole (sAS) interactions have almost no effect on 
enantioselectivity. 
4.4.3 Normalized factors of selectivity 
Given the striking similarity in the factors that control enantioselectivity of amino 
acids, and the similarity of these factors to the factors that compose enantioselectivity for 
unrelated compounds, a plot of normalized factors of selectivity was constructed (Table VII). 
The factors of enantioselectivity for every compound in this study are displayed, normalized 
to -vAV (Fig. 6). The ranking of the factors of enantioselectivity can vary significantly 
between the different types of intermolecular interactions. Arginine has values of sAS and 
aAA that are close to the middle of the distribution of values for these interactions, but the 
bAB term for arginine is the lowest of all compounds. Bromacil has a value of bAB that is 
close the middle of the distribution for this interaction, but the aAA and sAS terms are the 
smallest of all compounds (excluding the compounds that do not possess acidic hydrogen 
atoms for the aAA type hydrogen bonding). Additionally, the values of eAE range from 0.73 
to 1.03 and are evenly distributed between these values, and not clustered near one value. 
From this, we conclude that the similarities in the factors of enantioselectivity for the 
compounds in this study are not due to interdependent interaction descriptors but are a 
consequence the mode of operation utilized, and the interactions that the chiral selector 
teicoplanin is capable of undergoing in that mode. 
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4.4.4 Contrast in the factors of enantioselectivity for neutral compounds vs. amino acids 
While there are several common factors that contribute to the enantioselectivity of 
both the neutral molecules and amino acids, there are at least three interactions that 
contribute to enantioselectivity for every case. The three-point model of chiral recognition 
states that a minimum of three simultaneous yet differing interactions about the stereogenic 
center are required to differentiate between enantiomers [21, 88-90]. It is possible to have 
four or more interactions contributing to enantioselectivity, but a minimum of three is 
required. While some of the neutral molecules have three separate intermolecular 
interactions that contribute to enantioselectivity, and some have four, all of the amino acids 
examined have at least four separate interactions that contribute to enantioselectivity (and 
some have five). This higher number of interactions is most likely due to the constituent 
groups of amino acids (the carboxylate group, ammonium group, and side chain) 
participating in multiple interactions. For example, both the ammonium group and the 
carboxylate groups can participate in ion-dipole interactions and hydrogen bonding. While a 
molecule's ability to participate in intermolecular interactions is a contributing factor (to the 
number of interactions that can potentially generate enantioselectivity), it is also possible 
(and even likely) that the differences observed between the neutral molecules and amino 
acids are due to the chiral recognition process occurring at different sites on the teicoplanin 
chiral selector. 
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4.5 Conclusions 
The LSER model can be used to successfully describe both retention and 
enantioselectivity on the teicoplanin CSP in the reversed-phase mode. The major factors that 
contribute to the separation of enantiomers are ion-dipole interactions and steric repulsion, 
with the hydrogen bonding ability of the chiral selector having a moderate impact on 
enantioselectivity. Dipole-dipole interactions seem to have almost no contribution to 
enantioselectivity but do contribute to the overall retention of these compounds. The relative 
importance of three polar interaction terms (sAS, aAA, and bAB) varies for each compound 
analyzed, as demonstrated by the normalized factors of selectivity. Differences in the 
mechanism of enantioseparation due to changes in the mobile phase (identity of organic 
modifier and presence of buffer salts) also can be identified by this method of analysis. All 
of the compounds examined experience enantioselective interactions from at least three 
different types of intermolecular interactions, and all of the amino acids examined experience 
enantioselective interactions from at least four different types of intermolecular interactions. 
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Figure 1. Structure of chiral solutes. Chiral centers are denoted with an asterisk. 
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Figure 2. a) Solute descriptors for the enantiomers of 5-methyl-5-phenyl-hydantoin, 
determined by linear regression (see theoretical & experimental), b) Factors that contribute 
to the retention of the enantiomers of 5-methyl-5-phenyl-hydantoin. c) Factors that 
contribute to the enantioselectivity of 5-methyl-5-phenyl-hydantoin. The factors of retention 
and enantioselectivity are calculated with the solute descriptors obtained from regression and 
system constants for the teicoplanin CSP at 25/75 ethanol/buffer mobile phase at 25°C, 
according to equations 1 and 6, respectively. 
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Figure 3. Plot of predicted vs. observed enantioselectivity for all solutes in this study. 
Predicted enantioselectivities are calculated for the teicoplanin CSP at 25/75 ethanol/buffer 
mobile phase at 25°C, and the observed enantioselectivity came from measurements at this 
condition. 
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Figure 4. Comparison of factors that contribute to enantioselectivity for a-naphthalenyl 
methyl sulfoxide in two different mobile phases. 
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Figure 6. Factors of enantioselectivity, normalized to -vAV. The y-axis scale is reduced to 
enhance the view of the polar interaction terms, sAS, aAA, and bAB. Compound one is 5-
methyl-5-phenyl-hydantoin, 2 is bromacil, 3 is dihydrofurocoumarin, 4 is l,l-dimethyl-3-
phenyl-propyl toluyl sulfoxide, 5 is a-naphthalenyl methyl sulfoxide, 6 is arginine, 7 is 
methionine, 8 is m-tyrosine, 9 is phenyl glycine, 10 is tyrptophan, 11 is N-acetyl-m-fluoro-
phenylalanine, and 12 is N-benzoyl-phenylalanine. 
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Supplemental Table I. LSER probe solutes and their descriptors. Solute descriptors E, S, 
A, B, and V are defined in the Introduction. 
Solute E S A B V 
1,3-benzenediol 0.980 1.00 1.10 0.58 0.834 
1 -nitrobutane 0.227 0.95 0.00 0.29 0.846 
4-ethylphenol 0.800 0.90 0.55 0.36 1.057 
3-cyanophenol 0.930 1.55 0.77 0.28 0.930 
benzonitrile 0.742 1.11 0.00 0.33 0.871 
acetophenone 0.818 1.01 0.00 0.48 1.014 
phenol 0.805 0.89 0.60 0.31 0.775 
2-nitrophenol 1.015 1.05 0.05 0.37 0.949 
1-nitropentane 0.212 0.95 0.00 0.29 0.987 
m-cresol 0.822 0.88 0.57 0.34 0.916 
p-cresol 0.820 0.87 0.57 0.31 0.916 
methyl-4-hydroxybenzoate 0.900 1.37 0.69 0.45 1.131 
nitrobenzene 0.871 1.11 0.00 0.28 0.891 
ethyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.272 
1 -nitrohexane 0.203 0.95 0.00 0.29 1.128 
benzene 0.610 0.52 0.00 0.14 0.716 
n-propyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.413 
4-chlorophenol 0.915 1.08 0.67 0.20 0.897 
toluene 0.601 0.52 0.00 0.14 0.857 
o-xylene 0.663 0.56 0.00 0.16 0.998 
m-xylene 0.623 0.52 0.00 0.16 0.998 
p-xylene 0.613 0.52 0.00 0.16 0.998 
3-chlorophenol 0.909 1.06 0.69 0.15 0.897 
valerophenone 0.800 0.95 0.00 0.50 1.437 
n-butyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.554 
1-naphthol 1.520 1.05 0.61 0.37 1.144 
ethylbenzene 0.613 0.51 0.00 0.15 0.998 
naphthalene 1.340 0.92 0.00 0.20 1.085 
hexanophenone 0.720 0.95 0.00 0.50 1.578 
heptanophenone 0.720 0.95 0.00 0.50 1.718 
n-propylbenzene 0.604 0.50 0.00 0.15 1.139 
dibenzothiophene 1.959 1.31 0.00 0.20 1.379 
n-buytlbenzene 0.600 0.51 0.00 0.15 1.280 
Supplemental Table II. System constants for Chirobiotic T CSP at different temperature and ratios of ethanol/buffer. r2 is 
coefficient of correlation, SE is the standard error of regression, F is the Fisher statistic, n is the number of solutes in the 
regression. 
Mobile Temperature 
Phase rc) e s a b V Intercept r2 SE F n 
5% EtOH 40 0.33 0.21 -0.50 -0.80 1.33 -1.38 0.99 0.042 685 34 
5% EtOH 25 0.39 0.28 -0.51 -0.69 1.35 -1.42 0.99 0.045 632 34 
5% EtOH 10 0.43 0.40 -0.54 -0.40 1.25 -1.40 0.99 0.039 787 34 
5% EtOH 5 0.45 0.41 -0.53 -0.45 1.28 -1.44 0.99 0.045 628 34 
10% EtOH 55 0.26 0.20 -0.45 -0.83 1.11 -1.24 0.99 0.040 551 34 
10% EtOH 40 0.32 0.20 -0.45 -0.77 1.17 -1.26 0.99 0.041 587 34 
10% EtOH 25 0.37 0.28 -0.47 -0.66 1.20 -1.33 0.99 0.039 691 34 
10% EtOH 10 0.41 0.39 -0.48 -0.62 1.14 -1.41 0.99 0.043 549 34 
10% EtOH 5 0.46 0.39 -0.48 -0.57 1.27 -1.45 0.99 0.046 568 34 
15% EtOH 40 0.28 0.23 -0.45 -0.85 1.08 -1.26 0.99 0.044 452 34 
15% EtOH 25 0.34 0.30 -0.47 -0.80 1.16 -1.36 0.99 0.045 493 34 
15% EtOH 10 0.41 0.38 -0.48 -0.66 1.19 -1.43 0.99 0.045 537 34 
15% EtOH 5 0.44 0.42 -0.48 -0.64 1.21 -1.47 0.99 0.047 513 34 
20% EtOH 25 0.32 0.26 -0.46 -0.73 1.03 -1.30 0.98 0.045 345 33 
20% EtOH 10 0.38 0.39 -0.49 -0.69 1.08 -1.36 0.99 0.045 489 34 
20% EtOH 5 0.40 0.41 -0.48 -0.67 1.11 -1.38 0.99 0.046 469 34 
25% EtOH 25 0.28 0.25 -0.47 -0.72 0.91 -1.23 0.98 0.045 284 33 
25% EtOH 10 0.35 0.31 -0.47 -0.68 1.00 -1.25 0.98 0.049 298 33 
25% EtOH 5 0.38 0.33 -0.48 -0.68 1.05 -1.28 0.98 0.054 271 33 
30% EtOH 25 0.24 0.23 -0.48 -0.67 0.75 -1.13 0.97 0.045 228 33 
30% EtOH 10 0.28 0.27 -0.48 -0.65 0.84 -1.09 0.98 0.046 253 33 
30% EtOH 5 0.30 0.27 -0.48 -0.69 0.91 -1.10 0.97 0.051 235 33 
Table I. Solute descriptors of the enantiomers of the neutral compounds in this study, obtained from ethanol/buffer mobile phase 
retention data, unless specified. Standard errors of the fitting coefficients are shown in parenthesis. 
Compound E S A B V r2 F SE n 
5-methyl-5-phenyl-hydantoin Peak 1 2.65 0.89 0 0.13 0.35 1.00 32767 0.020 22 
(0.30) (0.18) (0.03) (0.06) 
Peak 2 4.42 0.70 -0.71 -0.19 -0.33 0.99 11971 0.037 22 
(0.56) (0.35) (0.20) (0.08) (0.12) 
bromacil Peak 1 1.27 0.98 0.05 0.23 0.99 1.00 288421 0.006 20 
(0.10) (0.06) (0.03) (0.01) (0.02) 
Peak 2 2.01 0.94 -0.03 0.12 0.76 1.00 62504 0.015 20 
(0.23) (0.14) (0.08) (0.03) (0.05) 
substituted Peak 1 1.87 1.35 0 0.39 1.52 1.00 272052 0.012 23 
dihydrofu rocou ma ri n (0.18) (0.10) (0.02) (0.03) 
Peak 2 2.27 1.34 0 0.24 1.39 1.00 133689 0.017 23 
(0.26) (0.15) (0.02) (0.05) 
1,1-dimethyl-3-phenyl-propyl Peak 1 1.18 1.10 0 0.48 1.83 1.00 259420 0.012 22 
toluyl sulfoxide (0.17) (0.10) (0.01) (0.03) 
Peak 2 1.89 1.14 0 0.29 1.60 1.00 137099 0.017 22 
(0.25) (0.15) (0.02) (0.05) 
a-naphthalenyl methyl Peak 1 2.02 1.29 0 0.29 1.10 1.00 112530 0.016 23 
sulfoxide (0.23) (0.14) (0.02) (0.05) 
Peak 2 3.61 1.30 0 -0.21 0.43 0.98 28905 0.032 21 
(0.50) (0.30) (0.06) (0.11) 
a-naphthalenyl methyl Peak 1 1.93 1.61 0 0.40 1.14 1.00 1034245 0.003 12 
sulfoxide3 (0.03) (0.03) (0.02) (0.01) 
Peak 2 2.59 2.19 0 0.50 0.91 1.00 48179 0.013 12 
(0.22) (0.19) (0.15) (0.09) 
a) based on retention data from methanol/water mobile phases 
Table II. Factors that contribute to the retention of enantiomers. These values are the product of solute descriptors and system 
constants for the teicoplanin CSP at 25/75 ethanol/buffer & 25° C, unless specified. 
Compound eE sS aA bB vV 
5-methyl-5-phenyl-hydantoin Peak 1 0.75 0.23 0.00 -0.09 0.32 
Peak 2 1.25 0.18 0.33 0.14 -0.30 
bromacil Peak 1 0.36 0.25 -0.02 -0.17 0.91 
Peak 2 0.57 0.24 0.02 -0.09 0.69 
substituted dihydrofurocoumarin Peak 1 0.53 0.34 0.00 -0.28 1.39 
Peak 2 0.64 0.34 0.00 -0.17 1.27 
1,1-dimethyl-3-phenyl-propyl Peak 1 0.33 0.28 0.00 -0.35 1.67 
toluyl sulfoxide Peak 2 0.54 0.29 0.00 -0.21 1.46 
a-naphthalenyl methyl sulfoxide Peak 1 0.57 0.33 0.00 -0.21 1.00 
Peak 2 1.02 0.33 0.00 0.15 0.39 
a-naphthalenyl methyl sulfoxidea Peak 1 0.59 0.35 0.00 -0.11 0.93 
methanol water Peak 2 0.79 0.48 0.00 -0.14 0.74 
a) based on retention data from methanol/water mobile phases 
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Table III. Factors that contribute to the selectivity of enantiomers. These values are the 
differences in the factors of retention, calculated for a 25/75 ethanol/buffer mobile phase at 
25°C. 
Compound eAe sAS aAA bAB vAV 
5-methyl-5-phenyl-hydantoin 0.50 -0.05 0.33 0.23 -0.62 
bromacil 0.21 -0.01 0.04 0.08 -0.21 
substituted dihydrofurocoumarin 0.11 0.00 0.00 0.11 -0.12 
1,1 -dimethyl-3-phenyl-propyl toluyl sulfoxide 0.20 0.01 0.00 0.14 -0.21 
a-naphthalenyl methyl sulfoxide 0.45 0.00 0.00 0.36 -0.62 
a-naphthalenyl methyl sulfoxide a 0.20 0.13 0.00 -0.03 -0.19 
a) based on retention data from methanol/water mobile phases 
Table IV. Solute descriptors of amino acid enantiomers, obtained from ethanol/buffer mobile phase retention data. Standard 
errors of the fitting coefficients are shown in parenthesis. 
Compound Peak E S A B V r2 F SE n 
arginine 1 3.99 -0.37 -0.93 -0.80 -0.73 0.96 12440 0.027 21 
(0.46) (0.28) (0.15) (0.07) (0.11) 
2 5.19 -0.66 -1.24 -0.94 -1.17 0.97 16408 0.025 21 
(0.43) (0.26) (0.14) (0.06) (0.10) 
methionine 1 3.88 0.41 -0.32 -0.18 -0.97 0.97 1405 0.041 22 
(0.62) (0.39) (0.23) (0.09) (0.14) 
2 5.75 0.04 -1.02 -0.62 -1.69 0.95 1717 0.056 22 
(0.86) (0.54) (0.31) (0.12) (0.19) 
m-tyrosine 1 4.19 0.61 -0.08 -0.23 -0.83 0.98 2529 0.041 22 
(0.62) (0.39) (0.22) (0.09) (0.14) 
2 5.97 0.18 -0.94 -0.58 -1.54 0.97 2863 0.053 22 
(0.80) (0.50) (0.29) (0.12) (0.18) 
phenylglycine 1 3.81 0.29 -0.47 -0.29 -0.94 0.97 2190 0.038 22 
(0.58) (0.36) (0.21) (0.08) (0.13) 
2 6.40 -0.37 -1.96 -0.86 -1.98 0.96 3376 0.055 22 
(0.83) (0.52) (0.30) (0.12) (0.18) 
tryptophan 1 3.63 0.60 -0.48 -0.19 -0.46 0.98 6731 0.035 22 
(0.52) (0.33) (0.19) (0.07) (0.11) 
2 5.79 -0.19 -1.30 -0.54 -1.35 0.95 2714 0.061 22 
(0.93) (0.58) (0.34) (0.13) (0.21) 
N-acetyl-m-fluoro-phenylalanine 1 6.28 0.28 -1.01 -0.16 -1.41 0.92 716 0.109 22 
(1.66) (1.05) (0.61) (0.24) (0.37) 
2 9.11 0.03 -1.92 -0.88 -2.39 0.94 1824 0.106 22 
(1.61) (1.02) (0.59) (0.24) (0.36) 
N-benzoyl-phenylalanine 1 2.08 1.28 -0.18 0.45 0.57 0.96 2442 0.070 23 
(1.06) (0.66) (0.38) (0.15) (0.24) 
2 7.27 0.03 -1.26 -0.16 -1.00 0.96 2612 0.095 23 
(1.44) (0.9) (0.52) (0.21) (0.32) 
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Table V. Factors that contribute to the retention of amino acid enantiomers. These values 
are the product of solute descriptors and system constants for the teicoplanin CSP with a 
25/75 ethanol/buffer mobile phase at 25° C. 
Compound eE sS aA bB vV 
arginine Peak 1 1.13 -0.09 0.44 0.58 -0.66 
Peak 2 1.47 -0.17 0.58 0.67 -1.06 
methionine Peak 1 1.10 0.10 0.15 0.13 -0.88 
Peak 2 1.63 0.01 0.48 0.44 -1.54 
m-tyrosine Peak 1 1.19 0.16 0.04 0.17 -0.76 
Peak 2 1.69 0.05 0.44 0.42 -1.40 
phenylglycine Peak 1 1.08 0.07 0.22 0.21 -0.85 
Peak 2 1.81 -0.09 0.92 0.62 -1.80 
tryptophan Peak 1 1.03 0.15 0.23 0.14 -0.42 
Peak 2 1.64 -0.05 0.61 0.39 -1.23 
N-acetyl-m-fluoro-
phenylalanine Peak 1 1.78 0.07 0.47 0.12 -1.28 
Peak 2 2.58 0.01 0.90 0.64 -2.18 
N-benzoyl-phenylalanine Peak 1 0.59 0.33 0.09 -0.32 0.52 
Peak 2 2.06 0.01 0.59 0.11 -0.91 
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Table VI. Factors that contribute to the selectivity of amino acid enantiomers. These values 
are the differences in the factors of retention, calculated for a 25/75 ethanol/buffer mobile 
phase at 25°C. 
Compound eAe sAS aAA bAB vAV 
arginine 0.34 -0.07 0.14 0.09 -0.40 
methionine 0.53 -0.09 0.33 0.31 -0.66 
m-tyrosine 0.50 -0.11 0.40 0.25 -0.64 
phenylglycine 0.73 -0.17 0.70 0.41 -0.95 
tryptophan 0.61 -0.20 0.38 0.25 -0.82 
N-acetyl-m-fluoro-phenylalanine 0.80 -0.06 0.43 0.52 -0.90 
N-benzoyl-phenylalanine 1.47 -0.32 0.51 0.44 -1.43 
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Table VII. Factors of enantioselectivity normalized to -vAV. 
Compound eAE sAS aAA bAB vAV 
5-methyl-5-phenyl hydantoin 
bromacil 
dihydrofurocoumarin 
1,1 -dimethyl-3-phenyl-propyl toluyl sulfoxide 
a-naphthalenyl methyl sulfoxide 
arginine 
methionine 
m-tyrosine 
phenylglycine 
tryptophan 
N-acetyl-m-fluoro-phenylalanine 
N-benzoyl-phenylalanine 
0.808 -0.078 0.535 0.377 -1.000 
0.987 -0.043 0.175 0.366 -1.000 
0.927 -0.028 0.000 0.893 -1.000 
0.949 0.042 0.000 0.653 -1.000 
0.733 0.006 0.000 0.588 -1.000 
0.845 -0.180 0.357 0.236 -1.000 
0.793 -0.143 0.501 0.478 -1.000 
0.785 -0.168 0.630 0.390 -1.000 
0.774 -0.176 0.738 0.432 -1.000 
0.751 -0.246 0.470 0.308 -1.000 
0.894 -0.071 0.479 0.578 -1.000 
1.030 -0.223 0.354 0.306 -1.000 
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CHAPTER 5 
Factors that Contribute to Enantioselectivity in Macrocyclic Glycopeptide 
Chiral Stationary Phases in the Normal-phase Mode 
A paper submitted to Journal of Chromatography A 
Clifford R. Mitchell, Daniel W. Armstrong 
Abstract 
The linear solvation energy relationship, developed by Abraham, is utilized to study 
enantioselectivity on the Chirobiotic T chiral stationary phase in the normal-phase mode. It 
was found that the system constants, obtained from ethanol/heptane based mobile phases, 
were highly intercorrelated (which indicates that solute descriptors derived from these system 
constants would not be reliably determined). The solvents ethoxynonafluorobutane (ENFB) 
and 2,2,2-trifluoroethanol (TFE) were also used as mobile phase solvents, and the 
intercorrelation between the system constants, including those derived from ethanol/ENFB 
and TFE/ENFB based mobile phases, was sufficiently reduced. The factors that control 
enantioselectivity for 5-methyl-5-pheny 1-hydantoin were determined, and it was found that 
steric repulsion interactions, dipole-dipole interactions, and ^-electron complexation had the 
largest effect on enantioselectivity, while hydrogen bonding had very little effect on 
enantioselectivity. The quality of the regressions was sufficient to generate solute descriptors 
that where statistically different for the enantiomers of 5-methyl-5-phenyl-hydantoin. 
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5.1 Introduction 
The ability to determine which intermolecular interactions contribute to the separation 
of enantiomers is extremely desirable for the design of a chiral selector. Recently, we 
demonstrated that the linear solvation energy relationship (LSER), developed by Abraham, 
can be used to determine which intermolecular interactions occurring between a chiral 
selector and a pair of enantiomers contribute to retention and enantioselectivity [1]. The 
study focused on the enantioselectivity of the teicoplanin chiral selector in the reversed-phase 
mode. It was found that ion-dipole interactions and steric repulsion interactions had the 
greatest impact on the separation of enantiomers, with varying amounts of hydrogen bonding 
contributing to enantioselectivity and dipole-dipole interactions having almost no impact the 
separation of enantiomers (on the Chirobiotic T (teicoplanin) chiral stationary phase (CSP) in 
the reversed-phase mode). 
The normal-phase mode and the reversed-phase mode of liquid chromatography are 
considered to be different modes of operation because it has been presumed that retention 
and selectivity are due to different factors, i.e., different intermolecular interactions occurring 
between the analyte and stationary phase in each mode. While there have been extensive 
studies of retention theory in both modes of operation, it is rare that a comprehensive theory 
of retention has been applied to the same stationary phase in both modes of operation. To do 
so would unambiguously show that retention and selectivity are governed by different 
intermolecular forces in each mode of operation. 
The LSER theory developed by Abraham [2] states that the distribution of a solute in 
a biphasic system is due to the intermolecular interactions the solutes experiences in both 
phases, or mathematically: 
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Log K = c + eE + sS + aA + bB + vV (1) 
where the five terms of equation one account for the ability of both the system and the solute 
to participate in a given intermolecular interaction. The term for interactions through 
polarizable n and n electrons is (eE), the term for dipole-dipole interactions is (sS), the term 
for a solute donating a hydrogen atom and the system donating a lone pair of electrons in a 
hydrogen bond is (aA), the term for a solute donating a lone pair of electrons and the system 
donating a hydrogen atom in a hydrogen bond is (6B), and the term for dispersion 
interactions is (vV). The c term contains the chromatographic phase ratio. Each term 
contains two components; one component describes a solute's ability to participate in the 
specified interaction (the upper case letters which are called solute descriptors) and the other 
component describes the system's ability to participate in the specified interaction (the lower 
case letters that are called system constants). 
To apply the LSER to the study of enantioselectivity, the relationship between 
chromatographic selectivity and the terms of the LSER equation must be established. 
Chromatographic selectivity is defined by 
•» 
Taking the logarithm of this and rearranging gives 
Loga = Log = LogK2 - LogKx (3) 
Ki 
Substituting a LSER equation for each log K and rearranging gives 
Loga = \eE2 - eEx ) + - sS t  ) + (aA2 - aAx )+ {pB2 -bBx )+ (vV2 - vVx)+(c2 - c, )] (4) 
which can be reduced to the following 
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Loga = \eE2 - eE l  ) + (sS2 -sS, )+ (aA2 - aA t  )+ (bB2 - bB l  )+{vV2 - vVx )] (5) 
because the c-terms are constant and cancel each other. If we define, for the solute, 
descriptors AX as X2 - X,, we can simplify the selectivity expression to 
Loga = elSE + sàS + aAA + blsB + vAV (6) 
The terms of this equation, such as sAS, are components of chromatographic selectivity and 
indicate the relative importance of the specified interaction, in this case dipole-dipole 
interactions, to selectivity (or enantioselectivity). 
To perform this kind of analysis of enantioselectivity, it is necessary to determine the 
system constants for a given system (a chiral stationary phase and mobile phase condition) 
and the solute descriptors for the chiral solute. While both of these tasks have been 
performed for achiral stationary phases and solutes [2-20], we recently demonstrated that the 
LSER theory can be applied to chiral separations by determining the system constants [21] 
and solute descriptors [1] for the analysis of enantioselectivity. Briefly, a large set of system 
constants of a chiral stationary phase are determined, with achiral solutes, at a variety of 
conditions (mobile phase composition, temperature). The retention factors for the 
enantiomers of the selected racemate are also determined at these conditions. Then, with the 
system constants as the independent variables and the retention factors of a single enantiomer 
as the dependent variable, multiple linear regression is performed to obtain the solute 
descriptors of the enantiomer. The process is repeated for the other antipode. With the 
solute descriptors and system constants of a chiral solute and chiral stationary phase, it is 
possible to determine which intermolecular interactions generate enantioselectivity, 
according to equation 6. 
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An important consideration is the origin of the differences in the solute descriptors of 
chiral solutes. In an isotropic environment, enantiomers of a chiral molecule have identical 
physical and chemical properties, and therefore identical solute descriptors. In a chiral 
environment, those same enantiomers can have different physical and chemical properties. 
Because of this, any differences in the solute descriptors obtained from this method of 
analysis are indicative of the differences in solvation interactions that the chiral solute 
experiences with a chiral stationary phase. 
There are several ways that the LSER approach can be used to study 
enantioseparations. The first approach would be to identify the exact factors that influence 
enantioselectivity (as well as their relative importance) for compounds on a given CSP, in 
one mode of operation. This would allow more exact correlations to be drawn between 
molecular structure and the factors contributing to enantioselectivity. Alternatively, the 
LSER approach could be used to determine the factors that influence enantioselectivity for a 
single compound on different stationary phases in the same mode of operation. This would 
reveal the difference in separation mechanism between different CSPs. Finally, the LSER 
approach can be used to pinpoint the factors that influence enantioselectivity for a single 
compound on a single CSP in different modes of operation or with different mobile phase 
compositions. This would reveal the difference in separation mechanisms that are active in 
each particular mode. In this study, both the first and third types of comparisons will be 
made for enantiomeric separations in the normal-phase mode on the Chirobiotic T 
(teicoplanin) CSP. 
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5.2 Experimental 
5.2.1 Materials 
The Chirobiotic T stationary phase used was obtained from Advanced Separation 
Technologies (Whippany, NJ) and consisted of the teicoplanin chiral selector bonded to 5 |im 
spherical silica gel. The dimensions of the columns are 50 x 4.6 mm. 
Heptane was HPLC grade from Fisher (Fairlawn, NJ), ethanol was punctilious grade 
from Aaper alcohol (Shelbyville, KY), 2,2,2-trifluoroethanol was reagent plus grade from 
Aldrich (St. Louis, MO), and the ethoxynonafluorobutane was purchased as Novec 
Engineered Fluid HFE-7200 from 3M Co. (St. Paul, MN). All LSER probe solutes (Table I) 
and most chiral solutes were obtained from Aldrich (St. Louis, MO) in high purity grade 
(99% or greater). The chiral sulfoxides were from a previous synthetic preparation [22, 23]. 
5.2.2 Instrumental 
The HPLC system used consisted of a quaternary pump, an auto sampler, a UV VWD 
detector (1050, Hewlett Packard, Palo Alto, CA, USA), an integrator (3395, Hewlett 
Packard), and a Jetstream + column thermostat (Advanced Separation Technologies) capable 
of regulating column temperature from 0 to 80 °C. Mobile phases were degassed by 
sparging with helium for ~2 minutes. UV detection was carried out at 220 nm. 
5.2.3 Calculations 
Retention factors (k) were calculated using the equation k = (tr - tM)/t\i-
Enantioselectivity factors (a) were calculated using the formula a = kz/k]. Multiple linear 
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regression analysis and statistical calculations were performed using the program Analyse-it, 
a statistics package for Microsoft Excel. 
5.3 Results & Discussion 
The LSER probe solutes and 10 racemates were eluted from the teicoplanin CSP with 
normal-phase mobile phases at two different temperatures (5°C and 35°C). System constants 
for each mobile phase/temperature combination were obtained from the retention data of the 
LSER probe solutes via multiple linear regression, which generated good fits to the LSER 
equation. Correlation coefficients (r2) of these linear regressions were typically larger than 
0.98, and standard deviations were small in comparison to the fitting coefficients. 
Initially, conventional ethanol/heptane mobile phases were utilized at different 
temperatures. It was found that the system constants obtained from these data are highly 
intercorrelated (Table II). For example, the coefficient of correlation (r) between all of the 
"s" system constants and all of the "b" system constants is 0.97. This high degree of 
intercorrelation indicates that the system constants (for this set of ethanol/heptane data) are 
not independent variables. When analyzing data by regression, the values of the regressor 
variables (the system constants in this case) should be independent of each other to properly 
deconvolute their impact on the value of the dependent variable (log k). Consequently, the 
solute descriptors obtained from this data set will not be independently determined and 
should be considered unreliable. It was therefore necessary to use other normal-phase mobile 
phases that had different properties or were more orthogonal to the ethanol/heptane mobile 
phases. 
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Recently, we explored the use of ethoxynonafluorobutane (ENFB) as a replacement 
for hexane and heptane in normal-phase mobile phases for NP-HPLC/MS [24]. Kagan et al. 
first demonstrated the feasibility of ENFB as a normal-phase chromatography solvent for 
NP-LC/MS [25-27]. Novec Engineered Fluid HFE-7200 was initially marketed by 3M Co. 
as a cleaning fluid, deposition solvent, and heat transfer fluid. HFE-7200 is produced as an 
azeotropic mixture of ethyl nonafluorobutylether and ethyl nonafluoroisobutyl ether, two 
compounds with very similar properties [24]. Compared with hexane and heptane, it has 
lower flammability and volatility, with similar viscosities and UV-cutoffs, making it a good 
solvent for liquid chromatography. 
The LSER probe solutes and 10 racemates were eluted from the teicoplanin CSP with 
ethanol/ENFB mobile phases, and 2,2,2-trifluoroethanol/ENFB mobile phases. System 
constants for each mobile phase composition/temperature combination were obtained from 
the retention factors of the LSER probe solutes via multiple linear regression (Table III). The 
quality of the linear regressions for the TFE/ENFB system constants was similar to that of 
the ethanol/heptane (r2 -0.98), but the ethanol/ENFB regressions were slightly lower (r2 
-0.94). 
The intercorrelation between system constants of these three mobile phase systems 
(ethanol/heptane, ethanol/ENFB, TFE/ENFB) was greatly reduced (Table IV), compared 
with the original ethanol/heptane set of system constants. The correlation between the e- and 
v-terms is the largest (r = 0.76), and some care should be taken when these system constants 
are used to determine solute descriptors. While most of the racemates were well separated in 
the ethanol/heptane mobile phase, the enantioselectivity of the examined solutes was often 
much less in the mobile phases containing fluorinated solvents. Solute descriptors for the 10 
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racemates were determined from the retention data of each enantiomer and system constants 
from the three types of mobile phases, ethanol/heptane, ethanol/ENFB, and TFE/ENFB. 
Only the solute descriptors for 5-methyl-5-phenyl-hydantoin were statistically 
different from each other (Fig. 2A, Table V). The quality of the linear regressions for each 
enantiomer were fair (r2 -0.97 and 0.92 for the first and second eluting enantiomer, 
respectively). The factors that contribute to retention and enantioselectivity were calculated 
according to equations 1 and 6, respectively (Fig 2B and 2C). 
While some of the interactions accounted for in equation 6 require interpretation, 
others are very clear in that they indicate what is occurring between a solute and a stationary 
phase (or the enantiomer and the chiral selector). The dipolar (sAS) and hydrogen bonding 
terms (aAA and bAB) are straightforward. The sAS term describes dipole-dipole 
interactions, and for 5-methyl-5-phenyl-hydantoin the sAS is 0.21, and the sSi and sS% terms 
are 1.14 and 1.36. These values indicate the dipole-dipole interactions have a positive impact 
on both retention and enantioselectivity. The aAA hydrogen bonding term indicates a 
hydrogen bond being donated by the enantiomers, and accepted by the chiral selector, and the 
bAB hydrogen bonding term indicates a hydrogen bond being donated by the chiral selector, 
and accepted by the enantiomers. The aAA and bAB terms for 5-methyl-5-phenyl-hydantoin 
are -0.02 and -0.09, respectively. These values suggest that hydrogen bonding plays a very 
small role in enantioselectivity, and the first eluting enantiomer experiences more 
enantioselective hydrogen bonding than the second eluting enantiomer (because the delta 
terms are negative). The aA,, aA%, bBi, and bB] terms are all positive, indicating that 
hydrogen bonding does have a positive effect on retention. These three polar interactions 
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parameters indicate the same types of interactions in either the reversed-phase mode or the 
normal-phase mode. 
The vAV term requires more interpretation. In our previous reversed-phase mode 
study, we found that dispersion interaction had a negative effect on enantioselectivity [1], 
We interpreted this as being indicative of a steric repulsion interaction, because the first 
eluting enantiomer experiences more dispersion forces with the stationary phase than the 
second eluting enantiomer (indicated by the negative AV term), as is the case for separations 
influenced by steric repulsions. For 5-methyl-5-phenyl-hydantoin, the vAV is 0.25, and we 
interpret this as a steric repulsion for the same reason as in the reversed-phase mode (the AV 
term is negative). In the normal-phase mode, the "v" system constant is also negative, 
causing the product of vAV to be positive. 
The final interaction covered by the LSER theory is interactions through polarizable 
n- and ^-electrons (eAE). In the reversed-phase mode, we attribute interactions in this e-term 
to ion-dipole interactions [28]. However, in the normal-phase mode, any ionic groups 
present in the stationary phase will exist as ion-pairs that are not available for solvation 
interactions, and ionic solutes are poorly soluble in normal-phase solvents. Because ion-
dipole interactions are not a possibility in the normal-phase mode, ^-electron complexation is 
the only type of interaction that can be manifested in the e-term. With heptane-based mobile 
phases, the macrocyclic glycopeptide CSPs seem to have no ability to interact through %-
electron complexation (e-term is indistinguishable from zero, Table III) [21]. However, 
when using ENFB and other fluorinated solvents in the mobile phase, the e-term is positive 
(Table III). The positive e-term is a consequence of highly fluorinated molecules having 
negative E solute descriptors [2], Therefore, it seems that fluorinated solvents are good for 
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promoting rc-electron complexation interactions. The eAE term for 5-methyl-5-phenyI-
hydantoin is 0.12, indicating that ^-electron complexation has a positive effect on 
enantioselectivity. Additionally, the eEi and eE^ terms are 0.37 and 0.50, indicating that n-
electron complexation also has a positive effect on retention. 
5.3.1 Comparison of enantioselectivity in the normal-phase mode and the reversed-
phase mode 
The factors that make up enantioselectivity for 5-methy 1-5 -pheny 1-hydantoin were 
determined in the normal-phase mode and the reversed-phase mode (in a previous study) [1]. 
By comparing the factors contributing to enantioselectivity in each mode, one can determine 
exactly how the different modes of chromatography are active in separating enantiomers. 
The factors contributing to enantioselectivity for 5 -methyl-5 -pheny 1-hydantoin in the normal-
phase mode and the reversed-phase mode are shown in Figure 3. The only common factor to 
both modes is the role of steric repulsion interactions (vAV). The differences in the sign of 
the vAV term between the reversed-phase mode and the normal-phase mode are due to the 
sign of the system constant "v"; the sign of the AV term is negative in both modes. There is 
a great deal of contrast in the relative importance of the three polar interaction terms, sAS, 
aAA, and bAB. In the reversed-phase mode, we found that both types of hydrogen bonding 
had a positive effect on enantioselectivity, and dipole-dipole interactions had a negligible 
effect. In the normal-phase mode, the opposite is true. Dipole-dipole interactions have a 
positive effect, and the two types of hydrogen bonding have a smaller, almost negligible, 
negative effect on enantioselectivity. Finally, interactions through polarizable n- and n-
electrons (eAE) have a positive effect in both modes of operation; however, we attribute the 
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interactions to ion-dipole interactions in the reversed-phase mode and ^-electron 
complexation in the normal-phase mode. 
5.4 Conclusions 
The LSER approach can be used to examine enantioselectivity in the normal-phase 
mode of operation; however, a greater variety of mobile phase conditions must be used to 
offset the intercorrelation in the system constants from ethanol/heptane based mobile phases. 
Ethoxynonafluorobutane is a suitable replacement for heptane and reduces the 
intercorrelation in the system constants. It was found that, for 5-methyl-5-phenyl-hydantoin, 
enantioselectivity is composed of steric repulsion interactions, dipole-dipole interactions, and 
^-electron complexation. In the reversed-phase mode, enantioselectivity is composed of 
steric repulsion interactions, ion-dipole interactions, and hydrogen bonding. 
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Figure 1. a) Structure of the chiral selector teicoplanin. b) Structure of the solute 5-methyl-
5-phenyl-hydantoin. 
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Figure 2. a) Solute descriptors for each enantiomer of 5-methyl-5-pheny 1-hydantoin 
determined in the normal-phase mode on the Chirobiotic T CSP, determined by linear 
regression, b) The factors that contribute to the retention of each enantiomer of 5-methyl-5-
phenyl-hydantoin, determined according to equation 1. c) The factors that contribute to the 
enantioseparation of 5-methyl-5-phenyl-hydantoin, determined according to equation 6. 
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Figure 3. The factors that contribute to the enantioselectivity of 5-methyl-5-phenyl-
hydantoin in the reversed-phase mode and the normal-phase mode. 
Table I. Solute descriptors of LSER probe solutes. Solute descriptors E, S, A, B, and V are 
defined in the Introduction. 
E S A B V 
pyrene 2.808 1.71 0.00 0.28 1.5846 
dibenzothiophene 1.959 1.31 0.00 0.20 1.3791 
phenanthrene 2.055 1.29 0.00 0.26 1.4544 
anthracene 2.290 1.34 0.00 0.26 1.4544 
n-buytlbenzene 0.600 0.51 0.00 0.15 1.2800 
ethylbenzene 0.613 0.51 0.00 0.15 0.9980 
p-xylene 0.613 0.52 0.00 0.16 0.9982 
toluene 0.601 0.52 0.00 0.14 0.8573 
biphenyl 1.360 0.99 0.00 0.22 1.3242 
naphthalene 1.340 0.92 0.00 0.20 1.0854 
heptanophenone 0.720 0.95 0.00 0.50 1.7180 
hexanophenone 0.720 0.95 0.00 0.50 1.5780 
4-nitrotoluene 0.870 1.11 0.00 0.28 1.0315 
nitrobenzene 0.871 1.11 0.00 0.28 0.8906 
4-iodophenol 1.380 1.22 0.68 0.20 1.0333 
4-bromophenol 1.080 1.17 0.67 0.20 0.9501 
4-chlorophenol 0.915 1.08 0.67 0.20 0.8970 
benzonitrile 0.742 1.11 0.00 0.33 0.8711 
1-naphthol 1.520 1.05 0.61 0.37 1.1441 
o-cresol 0.840 0.86 0.52 0.30 0.9160 
n-butyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.5540 
n-propyl-4-hydroxybenzoate 0.860 1.35 0.69 0.45 1.4131 
ethyl-4-hyd roxy benzoate 0.860 1.35 0.69 0.45 1.2722 
methyl-4-hydroxybenzoate 0.900 1.37 0.69 0.45 1.1313 
phenol 0.805 0.89 0.60 0.31 0.7751 
3-cyanophenol 0.930 1.55 0.77 0.28 0.9300 
4-nitrophenol 1.070 1.72 0.82 0.26 0.9490 
aniline 0.955 0.96 0.26 0.53 0.8162 
acetanilide 0.870 1.40 0.50 0.67 1.1133 
pyridine 0.794 0.87 0.00 0.62 0.6753 
1,3-benzenediol 0.980 1.00 1.10 0.58 0.8338 
1,4 benzenediol 1.063 1.27 1.06 0.57 0.8338 
benazamide 0.990 1.50 0.49 0.67 0.9728 
phenylurea 1.100 1.33 0.79 0.79 1.0726 
acetaminophen 1.060 1.78 1.09 0.81 1.1720 
1,3,5-trihydroxybenzene 1.355 1.12 1.40 0.82 0.8925 
caffeine 1.500 1.60 0.00 1.33 1.3632 
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Table II. Correlation matrix of system constants obtained from 5-30% ethanol in heptane 
mobile phases on the Chirobiotic T CSP. 
s a b V 
s 1.00 
a 0.87 1.00 
b 0.97 0.79 1.00 
V -0.89 -0.62 -0.95 1.00 
Table III. System constants for Chirobiotic T CSP at various conditions, r2 is the coefficient of correlation, SE is the standard 
error of regression, F is the Fisher statistic, n is the number of solutes in the regression. 
MP" T e s a b V Intercept r2 SE F n 
30/70 EtOH/heptane 35°C 0 0.497 0.046 1.390 -0.761 -0.621 0.98 0.079 416.6 42 
25/75 EtOH/heptane 35°C 0 0.528 0.135 1.448 -0.790 -0.613 0.98 0.083 443.3 42 
20/80 EtOH/heptane 35°C 0 0.544 0.223 1.536 -0.826 -0.583 0.98 0.087 461.3 42 
15/85 EtOH/heptane 35 C 0 0.576 0.330 1.638 -0.864 -0.576 0.98 0.095 471.5 42 
10/90 EtOH/heptane 35°C 0 0.622 0.512 1.802 -0.923 -0.580 0.98 0.104 511.1 42 
5/95 EtOH/heptane 35°C 0 0.702 0.831 2.101 -0.996 -0.647 0.98 0.122 560.8 42 
25/75 EtOH/heptane 5'C 0 0.563 -0.021 1.664 -0.892 -0.458 0.97 0.104 325.9 42 
20/80 EtOH/heptane 5 C 0 0.576 0.065 1.723 -0.925 -0.415 0.97 0.107 339.6 42 
15/85 EtOH/heptane 5'C 0 0.595 0.180 1.819 -0.969 -0.358 0.97 0.113 357.5 42 
25/75 EtOH/ENFB 35°C 0.181 0.548 0.186 1.201 -0.542 -1.068 0.93 0.129 98.2 37 
20/80 EtOH/ENFB 35"C 0.170 0.553 0.286 1.245 -0.527 -1.038 0.94 0.127 116.4 37 
15/85 EtOH/ENFB 35°C 0.152 0.524 0.393 1.294 -0.504 -0.942 0.95 0.124 137.7 37 
10/90 EtOH/ENFB 35°C 0.142 0.559 0.559 1.423 -0.508 -0.946 0.96 0.131 164.0 37 
5/95 EtOH/ENFB 35°C 0.130 0.671 0.914 1.712 -0.544 -1.091 0.96 0.160 177.4 36 
25/75 EtOH/ENFB 5°C 0.183 0.567 0.008 1.333 -0.614 -0.896 0.92 0.142 78.7 37 
20/80 EtOH/ENFB 5°C 0.187 0.609 0.116 1.380 -0.612 -0.939 0.92 0.154 79.9 37 
30/70 TFE/ENFB 35"C 0.178 0.289 0.933 0.911 -0.596 -0.658 0.97 0.111 213.2 34 
25/75 TFE/ENFB 35°C 0.161 0.338 1.023 1.053 -0.615 -0.674 0.98 0.109 271.8 34 
20/80 TFE/ENFB 35°C 0.116 0.389 1.059 1.121 -0.597 -0.664 0.98 0.116 264.8 34 
15/85 TFE/ENFB 35°C -0.005 0.634 1.040 1.129 -0.573 -0.743 0.98 0.102 332.5 33 
30/70 TFE/ENFB 5'C 0.098 0.499 0.798 0.801 -0.701 -0.471 0.97 0.106 189.2 33 
25/75 TFE/ENFB 5°C 0.096 0.553 0.909 0.998 -0.733 -0.535 0.97 0.109 236.9 33 
a) MP - mobile phase 
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Table IV. Correlation matrix of system constants obtained from ethanol/heptane, 
ethanol/ENFB, and TFE/ENFB (5-30% alcohol in nonpolar modifier) mixtures on 
Chirobiotic T CSP. 
e s a b V 
e 1.00 
s -0.42 1.00 
a 0.19 -0.27 1.00 
b -0.56 0.65 -0.38 1.00 
V 0.76 -0.27 0.29 -0.66 1.00 
Table V. Solute descriptors, factors that contribute to retention and enantioselectivity in the normal phase mode on the 
Chirobiotic T CSP for 5-methyl-5-phenyl-hydantoin. 
E S A B V r2 F SE n 
Solute descriptors Peak 1 
Peak 2 
2.07 
2.74 
eE 
2.09 
2.48 
sS 
0.57 
0.44 
aA 
0.51 
0.44 
bB 
0.67 
0.21 
vV 
0.9727 
0.9237 
4556 
2549 
0.0528 
0.0876 
20 
20 
Factors that contribute 
to retention 
Peak 1 
Peak 2 
0.37 
0.50 
eAE 
1.14 
1.36 
sAS 
0.11 
0.08 
aAA 
0.61 
0.52 
bAB 
-0.37 
-0.11 
vAV 
Factors that contribute 
to 
enantioselectivity 
0.12 0.21 -0.02 -0.09 0.25 
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CHAPTER 6 
General Conclusions 
The research outlined in this dissertation has demonstrated a unique application of the 
linear solvation energy relationship (LSER) to the study of enantiomeric separations. For the 
first time, a comprehensive theory of retention has been applied to enantiomeric separations, 
and the intermolecular interactions that generate enantiomeric separations have been 
identified. By using existing methodology, it has proven to be very difficult to 
comprehensively determine which intermolecular interactions contribute to the separation of 
enantiomers. 
The identification of the intermolecular interactions that are manifested in the e-term 
of the LSER model was an important development for applying the LSER model to 
enantiomeric separations. It was found that both ion-dipole and K electron complexation 
interactions are accounted for in this e-term. While these two intermolecular interactions are 
not deconvoluted from each other, it is possible to assign the interaction accounted for by the 
e-term to one of these two interactions based on knowledge of the solute and system. In the 
normal-phase mode, ionic solutes are poorly solvated by the mobile phase solvents and likely 
exist as tightly held ion pairs which are unable to participate in solvation interactions. 
Therefore, any interaction through the e-term in the normal-phase mode is most likely due to 
7i electron complexation interactions. In the reversed-phase mode, n electron complexation is 
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a very weak interaction, and ionic groups are well solvated by the mobile phase solvents 
utilized. Therefore, any interaction through the e-term in the reversed-phase mode is most 
likely due to ion-dipole interactions. Additionally, most reversed-phase stationary phases do 
not possess nonbonding n or u electrons for n electron complexation. While macrocyclic 
glycopeptide CSPs (which are the focus of this dissertation) do have numerous nonbonding n 
or 7i electrons, they have a zero e-term in the normal-phase mode, indicating they do not 
readily participate in n electron complexation. In the reversed-phase mode, the amine and 
carboxylic acid groups will be ionized and able to participate in ion-dipole interactions. 
Therefore, in the reversed-phase mode, any interaction accounted for by the e-term is 
attributed to ion-dipole interactions. 
The system constants obtained from macrocyclic glycopeptide CSPs revealed the 
important differences between conventional stationary phases and the macrocyclic 
glycopeptide CSPs, as well as the differences between the four different macrocyclic 
glycopeptide CSPs. In the reversed-phase mode, the macrocyclic glycopeptide CSPs are 
much less retentive because of hydrophobic interactions (compared with conventional 
octadecyl stationary phases) and capable of participating in greater amounts of polar 
interactions, such as dipole-dipole and hydrogen bonding interactions. Additionally, the 
ionizable groups of the stationary phases (amine and carboxylic acid groups) contribute to 
retention through ion-dipole interactions. In the normal-phase mode, retention was found to 
be increased by hydrogen bonding and dipole-dipole interactions, while dispersion 
interactions decreased retention. Interactions through polarizable n and ^-electrons had no 
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impact on retention, which suggests that these stationary phases are not capable of 
participating in ^-electron complexation at the tested conditions. 
The characterization of enantioselectivity with the LSER approach is a very 
interesting and unique way of understanding chiral separations. The factors that contribute to 
both the retention and separation of the enantiomers of several chiral compounds were 
determined in the reversed-phase mode and the normal-phase mode. It was found that steric 
repulsion interactions and ion-dipole interactions have the greatest impact on 
enantioselectivity, and hydrogen bonding interactions had a lesser effect on 
enantioselectivity. Dipole-dipole interactions have almost no effect on enantioselectivity, for 
the compounds examined. Conversely, in the normal-phase mode, dipole-dipole interactions 
have the greatest impact on enantioselectivity, and hydrogen bonding interactions have the 
least impact on enantioselectivity. Steric repulsion and ^-electron complexation interactions 
were found to have a moderate impact on enantioselectivity. The normal-phase mode proved 
to be a more difficult mode of operation for the determination of enantiomeric solute 
descriptors. This is primarily because of the intercorrelation that exists between the system 
constants obtained from ethanol/heptane mobile phases. The use of more unconventional 
solvents resulted in a set of system constants that were independent of each other and 
permitted the independent determination of solute descriptors for enantiomers in the normal-
phase mode. 
Future efforts will focus on applying the LSER theory to enantiomeric separations 
achieved on other broadly applicable chiral stationary phases. By using the LSER approach 
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outlined in this dissertation, comparisons can be made between the separations achieved on 
structurally related chiral selectors (such as teicoplanin and teicoplanin aglycon) and 
unrelated chiral selectors (teicoplanin- and cyclodextrin-based chiral stationary phases). 
Additionally, the potential to study the differences in the enantiomers of chiral selectors is 
intriguing. It would be very difficult to obtain the enantiomer of many of the broadly 
applicable chiral selectors, such as cyclodextrins, linear derivatized carbohydrates, and 
macrocyclic glycopeptides (which includes the chiral selector utilized in this research, 
teicoplanin). However, there are a great number of small, low molecular weight chiral 
selectors that possess one or two stereogenic centers and are readily available in both stereo­
chemical configurations. Comparisons can be made between the solute descriptors of a 
single enantiomer. obtained from each configuration of chiral selector. 
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